TWI480047B - Extract of peony root cortex, method of preparing the same and application thereof - Google Patents

Extract of peony root cortex, method of preparing the same and application thereof Download PDF

Info

Publication number
TWI480047B
TWI480047B TW101128457A TW101128457A TWI480047B TW I480047 B TWI480047 B TW I480047B TW 101128457 A TW101128457 A TW 101128457A TW 101128457 A TW101128457 A TW 101128457A TW I480047 B TWI480047 B TW I480047B
Authority
TW
Taiwan
Prior art keywords
dna
extract
peony bark
uvb
bark extract
Prior art date
Application number
TW101128457A
Other languages
Chinese (zh)
Other versions
TW201406386A (en
Inventor
Chiahua Liang
Hsiouyu Ding
Tzunghan Chou
Original Assignee
Univ Chia Nan Pharm & Sciency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chia Nan Pharm & Sciency filed Critical Univ Chia Nan Pharm & Sciency
Priority to TW101128457A priority Critical patent/TWI480047B/en
Publication of TW201406386A publication Critical patent/TW201406386A/en
Application granted granted Critical
Publication of TWI480047B publication Critical patent/TWI480047B/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

牡丹皮萃取物及其製造方法暨應用Cortex peel extract, its manufacturing method and application

本發明是有關於一種牡丹皮萃取物及其製造方法,特別是有關於一種兼具DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性之牡丹皮萃取物及其製造方法。The present invention relates to a peony bark extract and a method for producing the same, and more particularly to a peony bark extract having a plurality of biological activities which combine DNA repair, inhibition of melanin production and oxidation resistance, and a method for producing the same.

近年來,由於國民生活水準的提升,使得現代人對於自己的儀容越來越重視。惟臭氧層日漸破壞,使得人們對於美白、淡斑及袪斑相關產品的需求量大增,因而化粧保養品的市場規模逐年擴大。此外,現代人對於健康觀念萌起,為避免因化學成分之化粧保養品傷害皮膚,因此中草藥天然物在保健食品與美容上的應用以普遍受到重視,尤其是將中草藥萃取物應用於化粧品中已成為全球趨勢,亦是目前國內化妝品及生技產業積極開發的重點。In recent years, due to the improvement of the standard of living of the people, modern people have paid more and more attention to their appearance. However, the depletion of the ozone layer has led to an increase in the demand for whitening, blemishes and freckle-related products, and the market size of cosmetic products has expanded year by year. In addition, modern people have a healthy concept, in order to avoid damage to the skin caused by chemical makeup products, the application of Chinese herbal medicines in health foods and beauty has been generally valued, especially the application of Chinese herbal extracts in cosmetics. To become a global trend is also the focus of the active development of the domestic cosmetics and biotechnology industry.

輻射與紫外線照射於生物體會形成光損傷,引起水腫、紅斑、曬斑、細胞凋亡和抑制免疫反應等,使皮膚細胞中的DNA造成光損傷。DNA光損傷為啟動細胞修復系統之首要信號分子,當DNA產生內生性DNA雙股斷裂(DSB)或外生性DNA單股斷裂(SSB)時,會改變DNA結構且導致一連串生理反應機制,使細胞週期停滯並啟動DNA修復機制。Radiation and ultraviolet radiation on the organism can cause photodamage, causing edema, erythema, sunburn, apoptosis, and suppression of immune responses, causing photodamage of DNA in skin cells. DNA photodamage is the primary signaling molecule in the initiation of cell repair systems. When DNA produces endogenous DNA double strand breaks (DSB) or exogenous DNA single strand breaks (SSB), it changes the DNA structure and leads to a cascade of physiological mechanisms that allow cells to The cycle is stagnant and the DNA repair mechanism is initiated.

上述之內生性DNA雙股斷裂(DSB)主要來自於細胞正常生理反應中所形成之甲基化物質(methylating species;MS)和活性氧物質(ROS),引發自由基攻擊細胞、生成細胞 毒性、無法進行修復,DNA雙股斷裂之損傷進行錯誤的修復,引發基因突變與致癌性。主要透過非同源末端接合修復(non-homologous end joining;NHEJ)和同源互換重組(Homologous recombination;HR)之機制進行修復。The above-mentioned endogenous DNA double-strand break (DSB) mainly comes from methylating species (MS) and reactive oxygen species (ROS) formed in normal physiological reactions of cells, which trigger free radicals to attack cells and produce cells. Toxicity, inability to repair, damage to DNA double-strand breaks, erroneous repair, triggering gene mutations and carcinogenicity. Repair is mainly performed by a mechanism of non-homologous end joining (NHEJ) and homologous recombination (HR).

上述之外生性DNA單股斷裂(SSB)則多因環境之紫外線、輻射、空氣、化學物質等外在因子,皆會誘導DNA產生損傷,影響細胞週期停滯、DNA轉錄或轉譯產生突變或斷裂損傷,藉由模板轉換(template switching)、跨損傷修復(translation synthesis;TLS)、配對錯誤修復(mismatch repair;MMR)、鹼基切除修復(base-excision repair;BER)、核甘酸切除修復(nucleotide-excision repair;NER),以修復各種DNA配對錯誤、突變或單股斷裂之損傷。The above-mentioned exogenous DNA single-strand break (SSB) is mostly caused by environmental external ultraviolet, radiation, air, chemical substances and other external factors, which will induce DNA damage, affect cell cycle arrest, DNA transcription or translation to produce mutation or breakage damage. , by template switching, translation synthesis (TLS), mismatch repair (MMR), base-excision repair (BER), nucleotide removal repair (nucleotide- Excision repair; NER) to repair damage to various DNA pairing errors, mutations or single strand breaks.

其次,紫外線能誘導皮膚組織產生黑色素(melanin)且使皮膚顏色變深,而黑色素的生成又與酪胺酸酶(tyrosinase)的活性以及酪胺酸酶相關蛋白-1(tyrosinase-related protein-1;TRP-1;DHICA oxidase)和TRP-2(tyrosinase-related protein-2;TRP-2;DOPA chrometautomerase)有著密不可分的關係。TRP-2可催化多巴色素(dopachrome)轉變為DHICA(5,6-dihydroxy indole carboxylic acid),TRP-1則可催化DHICA的氧化反應。Secondly, ultraviolet light can induce skin tissue to produce melanin and darken the skin color, while melanin production is combined with tyrosinase activity and tyrosinase-related protein-1. ; TRP-1; DHICA oxidase) and TRP-2 (tyrosinase-related protein-2; TRP-2; DOPA chrometautomerase) are inextricably linked. TRP-2 can catalyze the conversion of dopachrome to DHICA (5,6-dihydroxy indole carboxylic acid), while TRP-1 can catalyze the oxidation of DHICA.

近年來國內外對於酪胺酸酶活性之研究發表了許多文獻報告,美白相關的研究探討更是炙手可熱。然而許多研究都在找尋可以抑制酪胺酸酶活性的物質,或其他方式機轉可以達到美白效果,目前已被確認可以有效抑制酪胺酸酶活性的成分為熊果素(arbutin;AR)、麴酸(kojic acid;KA) 和對苯二酚(hydroquinone;HQ)等,其中麴酸及熊果素皆為衛生署公告可添加之美白成份,對苯二酚則列為藥品管制。但各有其副作用,像是麴酸造成肝癌的產生(Tamotsuet al. ,2004),對苯二酚在許多國家用來治療色素沉著,當作藥物使用,但並不穩定且對黑色素細胞具毒性且易氧化。塗抹於皮膚上也可能會導致過敏、發紅與不適感(Teruhisaet al. ,2003;Halderet al. 2004),因此找尋一個安全且有效抑制黑色素生成的美白成分是有其必要性的。In recent years, many studies have been published on the study of tyrosinase activity at home and abroad, and the research on whitening is even more promising. However, many studies are looking for substances that can inhibit the activity of tyrosinase, or other ways to achieve whitening effect. The ingredients that have been confirmed to be effective in inhibiting tyrosinase activity are arbutin (AR) and tannin. (kojic acid; KA) and hydroquinone (HQ), among which tannic acid and arbutin are whitening ingredients that can be added by the Department of Health, and hydroquinone is classified as drug control. However, each has its side effects, such as citrate, which causes liver cancer (Tamotsu et al. , 2004). Hydroquinone is used in many countries to treat pigmentation and is used as a drug, but it is unstable and has a melanocyte Toxic and oxidizable. Applying to the skin may also cause allergies, redness and discomfort (Teruhisa et al. , 2003; Halder et al. 2004), so it is necessary to find a whitening ingredient that is safe and effective in inhibiting melanin production.

另外,皮膚的老化與疾病亦與自由基息息相關。除了因增齡而造成的內因性老化之外,皮膚尚受到環境諸多不利的影響,而加速或提前老化。這些外因性老化的原因例如,長期暴露於陽光或高能量放射線下、飲食不乾淨、組織受損、微生物感染、生活壓力過大、疲勞過度、或過多的油脂攝取等,也會增加自由基及黑色素的產生或是代謝因子喪失。人體內的反應性氧族(ROS),如超氧自由基( O2 - )以及過氧化氫(H2 O2 )在具有金屬離子的環境下能被轉變為具有高度活性的氫氧自由基( OH),對人體組織會造成最直接的傷害。過量的自由基累積於皮膚中,會造成表皮、真皮結締組織中的DNA受到破壞、脂質過氧化以及各種膠原蛋白質變性,使得結締組織失去原有功能,而產生皮膚老化的現象,例如皺紋、失去彈性以及乾燥等。In addition, skin aging and disease are also closely related to free radicals. In addition to the intrinsic aging caused by ageing, the skin is still adversely affected by the environment, accelerating or premature aging. These causes of exogenous aging, such as long-term exposure to sunlight or high-energy radiation, poor diet, tissue damage, microbial infections, excessive stress, excessive fatigue, or excessive oil intake, also increase free radicals and melanin. Production or loss of metabolic factors. Reactive oxygen species (ROS) in the human body, such as superoxide radicals ( O 2 - ) and hydrogen peroxide (H 2 O 2 ), can be converted into highly active hydrogen and oxygen free in the presence of metal ions. Base ( OH), which causes the most direct damage to human tissue. Excessive free radicals accumulate in the skin, causing damage to the DNA in the epidermis, dermal connective tissue, lipid peroxidation, and denaturation of various collagen proteins, causing connective tissue to lose its original function, resulting in skin aging phenomena such as wrinkles and loss. Elastic and dry.

有鑑於此,亟需提出一種DNA修復、抑制黑色素生成以及抗氧化的複數種生物的植物性物質,以期能提供化妝品組合物及/或食品添加物。In view of the above, it is urgent to propose a plant material of a plurality of organisms for DNA repair, inhibition of melanin production, and oxidation resistance, in order to provide a cosmetic composition and/or a food additive.

因此,本發明之一態樣是在提供一種牡丹皮萃取物,其中此牡丹皮萃取物為苯乙酮類化合物,且兼具DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性,並可進一步應用於化妝品組合物及/或食品添加物。Therefore, one aspect of the present invention provides a peony bark extract, wherein the peony bark extract is an acetophenone compound and has a plurality of biological activities including DNA repair, inhibition of melanin production and oxidation resistance, and Further applied to cosmetic compositions and/or food additives.

其次,本發明之另一態樣是在提供一種牡丹皮萃取物之製造方法,其係利用複數種有機溶液經由至少一分配萃取步驟以及至少一管柱分離步驟,以從牡丹皮材料獲得牡丹皮萃取物,此牡丹皮萃取物為苯乙酮類化合物且兼具DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性。Next, another aspect of the present invention provides a method for producing a peony bark extract, which comprises obtaining a peony bark from a peony bark material by using at least one partitioning extraction step and at least one column separation step using a plurality of organic solutions. The extract, the peony bark extract is an acetophenone compound and has multiple biological activities including DNA repair, inhibition of melanin production, and oxidation resistance.

根據本發明之上述態樣,提出一種牡丹皮萃取物,此牡丹皮萃取物為如式(I)所示之2,5-二羥基-4-甲基苯乙酮(2,5-dihydroxy-4-methylacetophenone): 且此牡丹皮萃取物兼具DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性。According to the above aspect of the present invention, there is proposed a peony bark extract which is 2,5-dihydroxy-4-methylacetophenone (2,5-dihydroxy- as shown in the formula (I). 4-methylacetophenone): Moreover, this peony bark extract has multiple biological activities including DNA repair, inhibition of melanin production and oxidation resistance.

根據本發明之另一態樣,提出一種化妝品組合物,其特徵在於此化妝品組合物至少包含一有效含量之上述牡丹皮萃取物,以提供DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性。According to another aspect of the present invention, a cosmetic composition is provided, characterized in that the cosmetic composition comprises at least an effective amount of the above-mentioned peony bark extract to provide a plurality of biological activities for DNA repair, inhibition of melanin production and oxidation resistance. .

根據本發明之又一態樣,提出一種食品添加物,其特徵在於此化妝品組合物至少包含一有效含量之上述牡丹皮萃取物,以提供DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性。According to still another aspect of the present invention, a food additive is provided, characterized in that the cosmetic composition comprises at least an effective amount of the above-mentioned peony bark extract to provide a plurality of biological activities for DNA repair, inhibition of melanin production and oxidation resistance. .

根據本發明之再一態樣,提出一種牡丹皮萃取物之製造方法。在一實施例中,首先利用第一有機溶液對牡丹皮材料進行至少一粗萃取步驟,以獲得粗萃取物。接著,利用第二有機混合溶液對前述粗萃取物進行第一分配萃取步驟,以劃分出第一有機相以及第二有機相,其中第一有機相包含第一萃取物。然後,利用第三有機水溶液對前述第一萃取物進行第二分配萃取步驟,以劃分出第三有機相以及水相,其中第三有機相包含第二萃取物。之後,對前述第三有機相進行第一管柱分離步驟,以根據分子量大小依序獲得第一溶離液(eluate)與第二溶離液。隨後,對前述第二溶離液進行第二管柱分離步驟,以分離出牡丹皮萃取物,其係如前式(I)所示之2,5-二羥基-4-甲基苯乙酮。According to still another aspect of the present invention, a method of producing a peony bark extract is provided. In one embodiment, the peony bark material is first subjected to at least one crude extraction step using a first organic solution to obtain a crude extract. Next, the crude extract is subjected to a first partition extraction step using a second organic mixed solution to divide the first organic phase and the second organic phase, wherein the first organic phase comprises the first extract. Then, the first extract is subjected to a second partition extraction step using a third organic aqueous solution to divide the third organic phase and the aqueous phase, wherein the third organic phase comprises the second extract. Thereafter, the first column separation step is performed on the third organic phase to sequentially obtain the first eluate and the second dissolving solution according to the molecular weight. Subsequently, the second separation column is subjected to a second column separation step to separate the peony bark extract, which is a 2,5-dihydroxy-4-methylacetophenone as shown in the above formula (I).

依據本發明一實施例,上述之第一有機溶液例如可為乙醇溶液。在一個例子中,於上述至少一粗萃取步驟之後,更至少包含進行濃縮步驟,以去除粗萃物之第一有機溶液。According to an embodiment of the invention, the first organic solution may be, for example, an ethanol solution. In one example, after the at least one crude extraction step, at least a concentration step is performed to remove the first organic solution of the crude extract.

上述之第二有機溶液例如可為正己烷/甲醇溶液,且上述之第三有機溶液例如可為乙酸乙酯/水溶液,而上述之第一有機相例如可為甲醇相。在一個例子中,於上述第一分配萃取步驟之後,更至少包含去除第一有機相之甲醇,以獲得第一萃取物。The second organic solution may be, for example, a n-hexane/methanol solution, and the third organic solution may be, for example, an ethyl acetate/water solution, and the first organic phase may be, for example, a methanol phase. In one example, after the first partitioning extraction step described above, at least the methanol from the first organic phase is removed to obtain a first extract.

依據本發明一實施例,上述之第三有機溶液例如可為 乙酸乙酯/水溶液,而上述之第三有機相例如可為乙酸乙酯相。According to an embodiment of the invention, the third organic solution may be, for example, Ethyl acetate/water solution, and the third organic phase described above may be, for example, an ethyl acetate phase.

依據本發明一實施例,上述之第一管柱分離步驟係利用第一管柱以及第一沖提液進行。在一個例子中,第一管柱例如可為葡萄糖凝膠層析管柱(Sephadex LH-20 gel chromatography column),而第一沖提液例如可為甲醇。According to an embodiment of the invention, the first column separation step is performed by using the first column and the first extract. In one example, the first column can be, for example, a Sephadex LH-20 gel chromatography column, and the first extract can be, for example, methanol.

依據本發明一實施例,在第一分配萃取步驟之後,更至少包含去除第一有機相之甲醇,以獲得第一萃取物。According to an embodiment of the invention, after the first partitioning extraction step, at least the methanol of the first organic phase is removed to obtain the first extract.

依據本發明一實施例,上述之第二管柱分離步驟係利用第二管柱以及依序利用第二沖提液、第三沖提液與第四沖提液進行,以依序分離出第三溶離液、第四溶離液與一第五溶離液,且第四溶離液包含上述牡丹皮萃取物。在一個例子中,前述之第二管柱例如可為粒徑70網目(mesh)至230網目之矽膠60(Silica gel 60)管柱,第二沖提液為正己烷/乙酸乙酯,第三沖提液為乙酸乙酯,且第四沖提液為甲醇。According to an embodiment of the present invention, the second column separation step is performed by using the second column and sequentially using the second extract liquid, the third extract liquid and the fourth extract liquid to sequentially separate the first step. a third eluent, a fourth eluate and a fifth eluate, and the fourth eluate comprises the above-mentioned peony bark extract. In one example, the second column can be, for example, a mesh size of 70 mesh to 230 mesh Silica gel 60 column, and the second extract is n-hexane/ethyl acetate, third. The extract was ethyl acetate and the fourth extract was methanol.

依據本發明一實施例,上述之牡丹皮萃取物或粗萃取物兼具DNA修復、抑制黑色素生成以及抗氧化的複數種生物活性。According to an embodiment of the present invention, the above-mentioned peony bark extract or crude extract combines a plurality of biological activities of DNA repair, inhibition of melanin production and oxidation resistance.

應用本發明之牡丹皮萃取物及其製造方法,其係藉由至少一分配萃取步驟以及至少一管柱分離步驟,以獲得牡丹皮萃取物,其中此牡丹皮萃取物為如式(I)所示之苯乙酮類化合物。此苯乙酮類化合物兼具DNA修復、抑制黑色素生成以及抗氧化的生物活性,可應用於化妝品組合物及/或食品添加物。The peony bark extract of the present invention and the method for producing the same are provided by at least one partitioning extraction step and at least one column separation step to obtain a peony bark extract, wherein the peony bark extract is of the formula (I) Acetophenone compounds. The acetophenone compound has both biological effects of DNA repair, inhibition of melanin production, and antioxidant activity, and can be applied to cosmetic compositions and/or food additives.

承前所述,本發明提供一種牡丹皮萃取物及其製造方法,其係利用至少一分配萃取步驟以及至少一管柱分離步驟,以獲得兼具DNA修復、抑制黑色素生成以及抗氧化等生物活性的牡丹皮萃取物。As described above, the present invention provides a peony bark extract and a method for producing the same, which utilize at least one partitioning extraction step and at least one column separation step to obtain biological activities such as DNA repair, inhibition of melanin production, and oxidation resistance. Mudan peel extract.

本文此處所稱之「牡丹皮」係指毛茛科(Ranunculaceae )芍藥屬(Paeonia )牡丹(Paenoina Suffruticosa )的根皮(root cortex)。牡丹皮是一種中草藥,在中醫上主要用來提供涼血、清熱、活血及散瘀的功能。本發明使用之牡丹皮係經林漢欽博士確認後,即利用本發明以下揭露之方法獲得苯乙酮類化合物類的牡丹皮萃取物。The paper referred to here, "Paeonia" means Paeonia Ranunculaceae (Ranunculaceae) (Paeonia) Peony (Paenoina Suffruticosa) root bark (root cortex). Mudanpi is a kind of Chinese herbal medicine. It is mainly used in traditional Chinese medicine to provide functions of cooling blood, clearing away heat, promoting blood circulation and dispersing phlegm. After the peony bark used in the present invention is confirmed by Dr. Lin Hanqin, the acetophenone compound-like peony bark extract is obtained by the method disclosed in the present invention.

請參閱第1圖,其係繪示根據本發明一實施例之牡丹皮萃取物之製造方法流程圖。首先,牡丹皮萃取物之製造方法100可如步驟101所示,提供牡丹皮材料。在一個例示中,牡丹皮材料可為乾燥粉末,一般可係於室溫或略低於室溫之溫度下,利用粉碎機打碎牡丹皮而形成牡丹皮乾燥粉末。Please refer to FIG. 1 , which is a flow chart showing a method for manufacturing a peony bark extract according to an embodiment of the present invention. First, the method 100 of producing a peony bark extract can provide a peony bark material as shown in step 101. In an illustration, the peony bark material may be a dry powder, which may be broken at room temperature or slightly below room temperature, and the peony bark is broken by a pulverizer to form a dry powder of peony bark.

接著,如步驟103所示,利用第一有機溶液,例如乙醇溶液,對前述之牡丹皮材料101進行粗萃取步驟,以獲得粗萃物。在一例示中,前述之乙醇溶液之濃度可例如為至少95體積百分比[%(v/v)]。Next, as shown in step 103, the aforementioned peony skin material 101 is subjected to a crude extraction step using a first organic solution, such as an ethanol solution, to obtain a crude extract. In one example, the concentration of the aforementioned ethanol solution may be, for example, at least 95 volume percent [% (v/v)].

在此補充說明的是,本發明所屬技術領域中任何具有通常知識者應可理解,在進行前述粗萃取步驟時,可進一步進行固液分離處理,利用紗布、濾紙、離心或其他方式 處理一次或重複數次後,去除牡丹皮材料101之殘渣,並合併所得濾液。It should be further noted that any one of ordinary skill in the art to which the present invention pertains should be able to understand that the solid-liquid separation process may be further performed by using the gauze, filter paper, centrifugation or the like. After one treatment or several times of repetition, the residue of the peony skin material 101 is removed, and the resulting filtrate is combined.

在前述固液分離處理後,前述濾液更可選擇性進行濃縮步驟,例如利用減壓濃縮法、真空濃縮法等習知方式,去除前述濾液之乙醇溶液,以獲得粗萃物。After the solid-liquid separation treatment, the filtrate may be selectively subjected to a concentration step, and the ethanol solution of the filtrate may be removed by a conventional method such as a vacuum concentration method or a vacuum concentration method to obtain a crude extract.

之後,利用至少一分配萃取步驟以及至少一管柱分離步驟,以獲得牡丹皮萃取物。本文此處所稱之「至少一分配萃取步驟」,實指利用不同極性的有機溶劑系統對牡丹皮材料進行分配萃取。Thereafter, at least one partitioning extraction step and at least one column separation step are utilized to obtain a peony bark extract. As used herein, "at least one partitioning extraction step" refers to the partition extraction of peony bark material using an organic solvent system of different polarity.

申言之,在一實施例中,如步驟105所示,可利用第二有機混合溶液,例如正己烷/甲醇溶液,對上述之粗萃取物進行第一分配萃取步驟,以劃分(partition)出第一有機相以及第二有機相,其中第一有機相為甲醇相,且第一有機相包含第一萃取物。在一例示中,前述第二有機混合溶液之甲醇為95%(v/v)之甲醇溶液,且第二有機混合溶液之正己烷與甲醇之體積比例如可為1:1。In an embodiment, as shown in step 105, the first extraction extraction step may be performed on the crude extract by using a second organic mixed solution, such as a n-hexane/methanol solution, to partition. a first organic phase and a second organic phase, wherein the first organic phase is a methanol phase and the first organic phase comprises a first extract. In one example, the methanol of the second organic mixed solution is a 95% (v/v) methanol solution, and the volume ratio of n-hexane to methanol of the second organic mixed solution may be, for example, 1:1.

在步驟105之後,可選擇性去除前述第一有機相之甲醇,以獲得第一萃取物。至於去除甲醇之方式,可採用前述獲得粗萃物相同之濃縮步驟或其他習知方式進行,此處不再贅述。After step 105, the methanol of the first organic phase described above may be selectively removed to obtain a first extract. As for the manner of removing the methanol, the same concentration step as the above-mentioned crude extract can be used or other conventional methods, and details are not described herein.

然後,如步驟107所示,利用第三有機水溶液,例如乙酸乙酯/水溶液,對前述第一萃取物進行第二分配萃取步驟,以劃分出第三有機相以及水相,其中第三有機相為乙酸乙酯相,且第三有機相包含第二萃取物。在一例示中,前述之第三有機水溶液的乙酸乙酯與水之體積比可例如為 3:1。Then, as shown in step 107, the first extract is subjected to a second partition extraction step using a third organic aqueous solution, such as an ethyl acetate/water solution, to fractionate a third organic phase and an aqueous phase, wherein the third organic phase It is an ethyl acetate phase and the third organic phase contains a second extract. In an example, the volume ratio of ethyl acetate to water of the third organic aqueous solution may be, for example, 3:1.

之後,如步驟109所示,對前述第三有機相進行第一管柱分離步驟。在一例示中,第一管柱分離步驟係將第三有機相經由第一管柱並利用第一沖提液進行沖提,其中第一沖提液可例如為甲醇,而第一管柱可為市售分子篩層析管柱,根據分子量大小的不同,可依序獲得第一溶離液(分子量較大)與第二溶離液(分子量較小),其中第二溶離液即含有上述第二萃取物。Thereafter, as shown in step 109, a first column separation step is performed on the third organic phase. In an example, the first column separation step is to pump the third organic phase through the first column and with the first extract, wherein the first extract may be, for example, methanol, and the first column may be For the commercially available molecular sieve chromatography column, according to the difference in molecular weight, the first eluent (large molecular weight) and the second eluent (smaller molecular weight) can be sequentially obtained, wherein the second dissolving liquid contains the second extraction Things.

隨後,如步驟111所示,對前述第二溶離液進行第二管柱分離步驟,以分離出牡丹皮萃取物。在一例示中,第二管柱分離步驟係第二溶離液經由第二管柱,例如市售矽膠管柱,並依序利用極性大小不同的第二沖提液、第三沖提液與第四沖提液進行沖提,其中第二沖提液可例如為正己烷/乙酸乙酯(極性較小),第三沖提液可例如為乙酸乙酯(極性居中),第四沖提液可例如為甲醇(極性較大),且第二沖提液之正己烷與乙酸乙酯之體積比可例如為1:3。藉由極性大小不同的沖提液,可依序分離出第三溶離液(極性較小)、第四溶離液(極性居中)與第五溶離液(極性較大),其中第四溶離液含有牡丹皮萃取物,其中此牡丹皮萃取物為苯乙酮類化合物,在一例示中,即如式(I)所示之2,5-二羥基-4-甲基苯乙酮: Subsequently, as shown in step 111, the second separation column is subjected to a second column separation step to separate the peony bark extract. In an example, the second column separation step is a second elution solution passing through a second column, such as a commercially available silicone column, and sequentially using a second extract having a different polarity, a third extract, and a third The fourth extract is for example, the second extract may be, for example, n-hexane/ethyl acetate (smaller polarity), and the third extract may be, for example, ethyl acetate (polar centered), the fourth extract. For example, it may be methanol (more polar), and the volume ratio of n-hexane to ethyl acetate of the second extract may be, for example, 1:3. The third eluent (smaller polarity), the fourth eluent (polar centered) and the fifth eluent (larger polarity) can be sequentially separated by the different polarity of the extract, wherein the fourth eluate contains An extract of peony bark, wherein the peony bark extract is an acetophenone compound, in an example, 2,5-dihydroxy-4-methylacetophenone as shown in formula (I):

在一實施例中,於第二管柱分離步驟之後,更可選擇性進行再結晶步驟,以利用甲醇由上述之第四溶離液獲得牡丹皮萃取物之結晶物。In one embodiment, after the second column separation step, a recrystallization step is further selectively performed to obtain crystals of the peony bark extract from the fourth solution described above using methanol.

上述所得之2,5-二羥基-4-甲基苯乙酮已知可抑制血小板聚集、抑制花生四烯酸(Arachidonic acid)形成血栓素(Thromboxane A2,TXA2)及前列腺素D2(Prostaglandin D2)之產物、調節血管擴張達到發汗與促進體熱消散作用。惟本發明經體外試驗進一步證實,上述所得之2,5-二羥基-4-甲基苯乙酮更兼具DNA修復、抑制黑色素生成以及抗氧化的生物活性,因此可應用於化妝品組合物及/或食品添加物。The 2,5-dihydroxy-4-methylacetophenone obtained above is known to inhibit platelet aggregation and inhibit the formation of thromboxane (Thromboxane A2, TXA2) and prostaglandin D2 (Prostaglandin D2) by Arachidonic acid. The product, regulates vasodilation to achieve sweating and promotes body heat dissipation. However, the present invention further confirmed by in vitro tests that the 2,5-dihydroxy-4-methylacetophenone obtained above has the biological activity of DNA repair, inhibition of melanin production and oxidation resistance, and thus can be applied to cosmetic compositions and / or food additives.

此處所稱之「DNA修復」的生物活性係指前述前述所得之牡丹皮萃取物可有效促進細胞內的DNA修復,減少細胞在UV照射後引起的傷害,進而提升細胞存活率。在本發明一個例子中,前述DNA修復的生物活性可藉由UV照射後之細胞存活率、彗星試驗等評估。The biological activity of "DNA repair" as used herein means that the aforementioned peony peel extract can effectively promote DNA repair in cells, reduce damage caused by UV irradiation, and thereby improve cell survival rate. In one example of the present invention, the biological activity of the aforementioned DNA repair can be evaluated by cell viability after UV irradiation, comet assay, and the like.

此處所稱之「抑制黑色素生成」的生物活性係指前述所得之牡丹皮萃取物可有效抑制酪胺酸酶之活性,進而減 少多巴醌(dopaquinone)以及黑色素的生成,進而達到皮膚美白之功效。申言之,造成皮膚色素沈著最主要的因素是由於暴露於紫外光照射,導致黑色素細胞內的黑色素合成,其中酪胺酸酶是催化黑色素合成的主要關鍵酵素。因此,在本發明一個例子中,前述之抑制黑色素生成的生物活性可藉由酪胺酸酶之活性抑制率、細胞外黑色素含量、細胞內黑色素含量以及多巴氧化酶(DOPA oxidase)之活性抑制率等評估。The biological activity referred to herein as "inhibiting melanin production" means that the aforementioned peony bark extract can effectively inhibit the activity of tyrosinase and further reduce The production of dopaquinone and melanin to achieve skin whitening effect. According to the statement, the most important factor causing skin pigmentation is the melanin synthesis in melanocytes due to exposure to ultraviolet light, which is the main key enzyme that catalyzes the synthesis of melanin. Therefore, in one example of the present invention, the aforementioned biological activity for inhibiting melanin production can be inhibited by the activity inhibition rate of tyrosinase, extracellular melanin content, intracellular melanin content, and activity of DOPA oxidase. Rate evaluation.

此處所稱之「抗氧化」的生物活性係指前述所得之牡丹皮萃取物可抑制。在本發明一個例子中,前述之抗氧化的生物活性可藉由過氧化氫(H2 O2 )經UV照射之光解作用後形成之羥基自由基,藉此模擬自由基對DNA的傷害而加以評估。The "antioxidant" biological activity referred to herein means that the aforementioned peony bark extract can be inhibited. In one example of the present invention, the aforementioned antioxidative biological activity can be formed by hydroxyl radicals formed by photolysis of hydrogen peroxide (H 2 O 2 ) by UV irradiation, thereby simulating the damage of DNA by free radicals. Evaluate.

值得一提的是,本發明之牡丹皮萃取物係依溶劑極性由高至低的順序進行至少一次分配萃取步驟後,再經由不同的管柱層析與沖提而萃取出如式(I)之牡丹皮萃取物。由於本發明之方法可找出牡丹皮中對DNA修復、抑制黑色素生成以及抗氧化更好且更有效的成分,因此可應用於化妝品組合物及/或食品添加物。It is worth mentioning that the peony bark extract of the present invention is subjected to at least one partitioning extraction step in the order of solvent polarity from high to low, and then extracted by the different column chromatography and extraction to obtain the formula (I). The peony bark extract. Since the method of the present invention can find a component which is better and more effective for DNA repair, inhibition of melanin production and oxidation resistance in the peony bark, it can be applied to a cosmetic composition and/or a food additive.

舉例而言,本發明所得之牡丹皮萃取物以及第一萃取物應用於化妝品組合物時,其形式可包括但不限於水劑、乳劑、膏劑、粉劑、美白劑、淡斑劑、袪斑劑或上述任意組合之化妝品。此外,本發明所得之牡丹皮萃取物應用於食品添加物時,其形式可包括但不限於營養品或保健食品。For example, when the peony bark extract and the first extract obtained by the present invention are applied to a cosmetic composition, the form may include, but not limited to, a liquid, an emulsion, an ointment, a powder, a whitening agent, a spotting agent, and a spotting agent. Or a cosmetic of any combination of the above. Further, when the peony bark extract obtained by the present invention is applied to a food additive, the form thereof may include, but is not limited to, a nutraceutical or a health food.

以下利用數個實施例以說明本發明之應用,然其並非 用以限定本發明,本發明技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。The following uses several embodiments to illustrate the application of the present invention, but it is not The present invention is intended to be limited to those skilled in the art, and various modifications and changes can be made without departing from the spirit and scope of the invention.

實施例一:牡丹皮萃取物之製備Example 1: Preparation of Cortex Mouth Extract

此實施例係利用第1圖之方法100製造牡丹皮萃取物。首先,如步驟101所示,進行粗萃取步驟,其係利用粉碎機,在室溫或略低於室溫之溫度下,打碎約10.0公斤之牡丹皮材料。This example produces a peony bark extract using the method 100 of Figure 1. First, as shown in step 101, a crude extraction step is carried out by using a pulverizer to break up about 10.0 kg of peony bark material at room temperature or slightly below room temperature.

接著,如步驟103所示,進行粗萃取步驟,其係將打碎之牡丹皮材料浸於95體積百分比之乙醇溶液後,進行固液分離步驟,其係利用紗布、濾紙、離心或其他方式處理一次或重複數次後,去除牡丹皮材料101之殘渣,並合併所得的濾液。在固液分離處理後,利用減壓濃縮法去除上述濾液之乙醇溶液後,獲得約1.48公斤牡丹皮之粗萃物。Next, as shown in step 103, a crude extraction step is performed, after the pulverized peony bark material is immersed in a 95 volume percent ethanol solution, and subjected to a solid-liquid separation step, which is treated by gauze, filter paper, centrifugation or the like. After one or several iterations, the residue of the peony bar material 101 was removed and the resulting filtrate was combined. After the solid-liquid separation treatment, the ethanol solution of the above filtrate was removed by a reduced pressure concentration method to obtain a crude extract of about 1.48 kg of peony bark.

之後,如步驟105所示,利用體積比1:1之正己烷/95%(v/v)甲醇溶液對上述粗萃物進行第一分配萃取步驟,以劃分出95%(v/v)甲醇相(約1.10 g)以及正己烷相(約330.0g),其中95%(v/v)甲醇相包含第一萃取物。Thereafter, as shown in step 105, the crude extract is subjected to a first partition extraction step using a volume ratio of 1:1 n-hexane/95% (v/v) methanol solution to fractionate 95% (v/v) methanol. Phase (about 1.10 g) and n-hexane phase (about 330.0 g), wherein the 95% (v/v) methanol phase comprises the first extract.

在步驟105之後,可選擇性利用前述獲得粗萃物相同之濃縮步驟或其他習知方式,去除前述95%(v/v)甲醇相之甲醇,以獲得第一萃取物。至於上述濃縮步驟或其他習知方式悉如前述,此處不再贅言。After step 105, the aforementioned 95% (v/v) methanol phase methanol may be selectively removed using the same concentration step as described above to obtain the crude extract or other conventional means to obtain the first extract. As for the above-mentioned concentration step or other conventional methods, as described above, it is no longer ambiguous here.

然後,如步驟107所示,利用體積比3:1之乙酸乙酯/水溶液,對前述第一萃取物進行第二分配萃取步驟,以劃分出乙酸乙酯相(約38.0g)以及水相(約1100.0g),其中乙酸 乙酯相包含第二萃取物。Then, as shown in step 107, the first extract is subjected to a second partition extraction step using an ethyl acetate/water solution having a volume ratio of 3:1 to fractionate the ethyl acetate phase (about 38.0 g) and the aqueous phase ( About 1100.0g), of which acetic acid The ethyl ester phase contains a second extract.

之後,如步驟109所示,對前述乙酸乙酯相進行第一管柱分離步驟,以將乙酸乙酯相經由市售分子篩層析管柱,例如葡萄糖凝膠層析管柱(Sephadex LH-20 gel chromatography column;Pharmacia Fine Chemicals AB Uppsala,Sweden),並利用甲醇作為沖提液進行沖提,根據分子量大小的不同,可依序獲得第一溶離液(分子量較大)與第二溶離液(分子量較小),其中第二溶離液即含有上述第二萃取物。Thereafter, as shown in step 109, the first column separation step is performed on the ethyl acetate phase to pass the ethyl acetate phase through a commercially available molecular sieve column, such as a glucose gel chromatography column (Sephadex LH-20). </ br> </ br> </ br> Smaller) wherein the second eluent contains the second extract described above.

隨後,如步驟111所示,對前述第二溶離液進行第二管柱分離步驟,以將第二溶離液經由例如粒徑70網目(mesh)至230網目之矽膠60(Silica gel 60)管柱(景明化工股份有限公司,ACME01-000000-40NL,印度),並依序利用體積比1:3之正己烷/乙酸乙酯(極性較小)、乙酸乙酯(極性居中)與甲醇(極性較大)進行沖提,依沖提收集的先後順序,每250毫升(mL)之溶離液收集成一瓶。所得之溶離液利用矽膠薄層色層層析析法(展開液為正己烷/乙酸乙酯(1:4)),檢測器為紫外光燈或碘試劑檢測成分,將相同成分的溶離液合併,可依序分離出三個部份,分別為第三溶離液、第四溶離液與第五溶離液。前述第四溶離液含有牡丹皮萃取物,且以甲醇進行再結晶,可得到化合物2,5-二羥基-4-甲基苯乙酮,具有如式(I)所示之結構: Subsequently, as shown in step 111, the second separation column is subjected to a second column separation step to pass the second solution to a column of silica gel 60 (silica gel 60) having a particle size of 70, for example, to a mesh size of (Jingming Chemical Co., Ltd., ACME01-000000-40NL, India), and using 1:3 by volume of n-hexane/ethyl acetate (smaller polarity), ethyl acetate (polar centered) and methanol (polarity) Large) For the extraction, each 250 ml (mL) of the solution is collected into a bottle according to the order of collection. The obtained eluent is subjected to a thin layer chromatography of tannin extract (the developing solution is n-hexane/ethyl acetate (1:4)), and the detector is an ultraviolet light or an iodine reagent detecting component, and the same component of the elution solution is combined. The three parts can be separated in sequence, which are the third eluent, the fourth dissolving solution and the fifth dissolving solution. The fourth eluent contains a peony bark extract and is recrystallized from methanol to obtain a compound 2,5-dihydroxy-4-methylacetophenone having a structure represented by the formula (I):

上述所得之2,5-二羥基-4-甲基苯乙酮經檢測後,其物化性質如下:分子量(MW)為166;溶點為141℃至142℃;UV(MeOH)λmax (log ε):211(4.07),232(4.16),265(3.97),359(3.64)nm;IR(KBr)v max :3330,1630 cm-11 H-NMR(δ mult.(J in Hz),CDCl3 ):H-9(2.25,s),H-8(2.53,s),H-3(6.75,s),H-6(7.08,s);13 C-NMR(δ,CDCl3 ):C-9(16.7),C-8(26.6),C-6(115.2),C-1(118.0),C-3(121.1),C-4(140.1),C-2(145.3),C-5(156.6),C-7(203.5);EI-MS m/z(rel.int.%):166([M]+ ,68),151(100)。The physicochemical properties of the 2,5-dihydroxy-4-methylacetophenone obtained above were as follows: molecular weight (MW) was 166; melting point was 141 ° C to 142 ° C; UV (MeOH) λ max (log ε): 211 (4.07), 232 (4.16), 265 (3.97), 359 (3.64) nm; IR (KBr) v max : 3330, 1630 cm -1 ; 1 H-NMR (δ mult. ( J in Hz ), CDCl 3 ): H-9 (2.25, s), H-8 (2.53, s), H-3 (6.75, s), H-6 (7.08, s); 13 C-NMR (δ, CDCl 3 ): C-9 (16.7), C-8 (26.6), C-6 (115.2), C-1 (118.0), C-3 (121.1), C-4 (140.1), C-2 (145.3) ), C-5 (156.6), C-7 (203.5); EI-MS m/z (rel.int.%): 166 ([M] + , 68), 151 (100).

上述之2,5-二羥基-4-甲基苯乙酮溶解於二甲基亞碸(dimethyl sulfoxide;DMSO),配置成100 mg/mL之濃度,放置於室溫備用。The above 2,5-dihydroxy-4-methylacetophenone was dissolved in dimethyl sulfoxide (DMSO), and was placed at a concentration of 100 mg/mL, and left at room temperature for use.

實施例二:評估牡丹皮萃取物之細胞毒性Example 2: Evaluation of cytotoxicity of peony bark extract

在此實施例中,首先係測試實施例一之牡丹皮萃取物2,5-二羥基-4-甲基苯乙酮)對於皮膚細胞、黑色素細胞或肝細胞,是否具有細胞毒性。適於測試用之皮膚細胞可例如為人類皮膚角質株化細胞(HaCaT;國立成功大學醫學院許漢銘醫師提供)以及人類皮膚纖維母細胞株(Hs68;BCRC編號:60038),測試用之黑色素細胞可例如為小鼠黑色素 瘤細胞株(B16;ATCC編號:CRL-6322),測試用之肝細胞可例如為小家鼠正常肝細胞(BNL CL.2;ATCC TIB-73),其中ATCC為美國典型菌種中心(American Type Culture Collection;ATCC)之簡稱,BCRC為臺灣新竹食品工業研究與發展研究所(Food Industry Research and Development Institute;FIRDI)的生物資源保存與研究中心(Bioresource Collection and Research Center;BCRC)之簡稱。In this example, the first test of the peony bark extract 2,5-dihydroxy-4-methylacetophenone of Example 1 was cytotoxic to skin cells, melanocytes or hepatocytes. Skin cells suitable for testing can be, for example, human skin keratinocytes (HaCaT; provided by Dr. Xu Hanming, National Chengchi University School of Medicine) and human skin fibroblast strain (Hs68; BCRC number: 60038), which can be used for testing melanocytes. Mouse melanin Tumor cell line (B16; ATCC number: CRL-6322), the hepatocytes for testing can be, for example, normal rat liver cells (BNL CL.2; ATCC TIB-73), wherein ATCC is a typical American species center (American Abbreviation for Type Culture Collection; ATCC, BCRC is the abbreviation of Bioresource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) in Taiwan.

上述細胞係利用無菌技術培養於細胞培養液中。HaCaT細胞株之細胞培養液為杜貝可改良之伊格氏培養液(Dulbecco’s Modified Eagle’s Medium,DMEM;Gibco,Grand Island,NY)並另添加10體積百分比之胎牛血清(fetal bovine serum;FBS;Hazelton Product,Denver,PA,U.S.A.)以及1 mM之丙酮酸鈉。B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞培養液為DMEM(Gibco,Grand Island,NY)並另添加10%(v/v)之FBS(fetal bovine serum;Hazelton Product,Denver,PA,U.S.A.)。The above cell lines are cultured in a cell culture medium using aseptic techniques. The cell culture medium of the HaCaT cell strain is Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Grand Island, NY) and an additional 10 volume percent of fetal bovine serum (FBS; Hazelton Product, Denver, PA, USA) and 1 mM sodium pyruvate. The cell culture medium of B16 cell line, BNL CL.2 cell line and Hs68 cell line was DMEM (Gibco, Grand Island, NY) and 10% (v/v) FBS (fetal bovine serum; Hazelton Product, Denver, PA, USA).

上述HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞置於5%的CO2 、95%的空氣以及37℃下之細胞培養箱中培養,依細胞狀況而定,大約每2至3天更換培養液。當細胞於培養皿之滿度(confluence)達約80%至約100%時,將培養液移除並以一倍(1×)的磷酸鹽緩衝溶液(phosphate buffered saline;PBS)清洗後,利用胰蛋白酶(trypsin,1×)使細胞形成單細胞懸浮液,然後進行繼代培養或進行實驗。The cells of the HaCaT cell line, the B16 cell line, the BNL CL.2 cell line, and the Hs68 cell line were cultured in a 5% CO 2 , 95% air, and a cell culture incubator at 37 ° C depending on the cell condition. The culture medium was changed approximately every 2 to 3 days. When the cell has a confluence of about 80% to about 100% in the culture dish, the culture solution is removed and washed with double (1×) phosphate buffered saline (PBS), and then utilized. Trypsin (1×) allowed the cells to form a single cell suspension, which was then subcultured or tested.

此時實施例係利用MTT法評估細胞存活率。申言之, 上述HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞,以1.0×105 /mL之細胞密度種植於96孔盤之每孔中,然後在37℃保持溼度之5%二氧化碳濃度下培養至少24小時。之後,將不同濃度(0至100μM)之實施例一的牡丹皮萃取物2,5-二羥基-4-甲基苯乙酮或維生素C(ascorbic acid,AA;抗壞血酸;Sigma Chemical Co,St.Louis,U.S.A.),分別添加於上述細胞中,其中維生素C係作為正對照組。培養72小時後,每孔細胞加入10 μL之溴化3-(4,5-二甲基唑-2)-2,5-二苯基四氮唑[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;MTT四氮唑;5 mg/mL],於37℃作用4小時後,移除上清液,再加入100 μL之二甲亞碸(dimethyl sulfoxide;DMSO;Sigma Chemical Co,St.Louis,U.S.A.)溶解MTT甲臢(MTT formazan;MTT四氮唑被還原後之產物),震盪10分鐘後,測量其於波長570 nm的吸光值以計算細胞存活率(cell viability),其結果如第2圖所示。上述吸光值之測量可根據例如CellTiter 96 AQ之使用手冊(CellTiter 96 AQ,Promega,Madison.WI,U.S.A.),利用例如多功能微量盤測讀機(Multi-Detection Microplate Reader;SynergyTM 2,BioTek Instruments,Inc.,U.S.A.)進行。At this time, the examples were evaluated for cell viability using the MTT method. In other words, the cells of the HaCaT cell line, the B16 cell line, the BNL CL.2 cell line, and the Hs68 cell line were planted in a well of a 96-well plate at a cell density of 1.0×10 5 /mL, and then at 37 ° C. Incubate for at least 24 hours while maintaining a humidity of 5% carbon dioxide. Thereafter, different concentrations (0 to 100 μM) of the peony bark extract of Example 1, 2,5-dihydroxy-4-methylacetophenone or vitamin C (ascorbic acid, AA; ascorbic acid; Sigma Chemical Co, St.) Louis, USA), respectively, was added to the above cells, wherein vitamin C was used as a positive control group. After 72 hours of culture, 10 μL of 3-(4,5-dimethylazole-2)-2,5-diphenyltetrazolium bromide [3-(4,5-dimethylthiazol-2) was added to each well of cells. -yl)-2,5-diphenyltetrazolium bromide; MTT tetrazolium; 5 mg/mL], after 4 hours at 37 ° C, the supernatant was removed, and 100 μL of dimethyl sulfoxide (DMSO) was added. ;Sigma Chemical Co, St. Louis, USA) Dissolved MTT formazan (MTT formazan; product of MTT tetrazolium after reduction), after 10 minutes of shaking, measured its absorbance at a wavelength of 570 nm to calculate cell viability ( Cell viability), the result is shown in Fig. 2. The above-mentioned absorbance measurement can be performed according to, for example, the CellTiter 96 AQ manual (CellTiter 96 AQ, Promega, Madison. WI, USA), using, for example, a Multi-Detection Microplate Reader; Synergy TM 2, BioTek Instruments , Inc., USA).

請參閱第2A圖至第2F圖,其係顯示根據本發明數個實施例之HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株與實施例一之牡丹皮萃取物或維生素C作用72小時後的細胞存活率曲線圖。第2A圖至第2F圖係以未經處理之對照組的細胞存活率(%)作為100%,其他 處理組之細胞存活率與未處理的對照組相比,經換算後所得之值,其中圖號●係代表HaCaT細胞株之細胞存活率曲線,圖號▲係代表B16細胞株之細胞存活率曲線,圖號◆係代表BNL CL.2細胞株之細胞存活率曲線,圖號■係代表Hs68細胞株之細胞存活率曲線,圖號☆係代表添加實施例一的牡丹皮萃取物2,5-二羥基-4-甲基苯乙酮之細胞存活率曲線,而圖號▽係代表添加維生素C之細胞存活率曲線。每筆數值至少由大於或等於3個樣本數所得出。Please refer to FIGS. 2A to 2F, which show HaCaT cell strain, B16 cell strain, BNL CL.2 cell strain and Hs68 cell strain according to several embodiments of the present invention, and the peony bark extract or vitamin of Example 1. A graph of cell viability after 72 hours of C action. Figures 2A to 2F show the cell survival rate (%) of the untreated control group as 100%, and others The cell survival rate of the treatment group was compared with that of the untreated control group, and the value obtained by the conversion, wherein the figure number ● represents the cell survival curve of the HaCaT cell line, and the figure number ▲ represents the cell survival rate curve of the B16 cell line. , Figure No. ◆ represents the cell viability curve of BNL CL.2 cell line, Figure No. ■ represents the cell viability curve of Hs68 cell line, and figure No. ☆ represents the addition of Peony peel extract of Example 1 2,5- The cell viability curve of dihydroxy-4-methylacetophenone, and the figure ▽ represents the cell viability curve of vitamin C addition. Each value is derived from at least 3 samples or more.

由第2A圖至第2F圖之結果可知,在HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株中添加高濃度(100 μM)之牡丹皮萃取物,影響細胞生長的程度較少,其細胞存活率仍維持約大於70%,因此實施例一之牡丹皮萃取物在添加濃度高達100 μM時,對上述細胞株並無細胞毒性。其次,由第2C圖以及第2E圖之結果可知,在HaCaT細胞株與B16細胞株中添加實施例一之牡丹皮萃取物的濃度越高,越可提升前述兩株細胞之細胞存活率。相較之下,由第2D圖之結果可知,添加高濃度(100 μM)之維生素C於BNL CL.2細胞株之細胞存活率僅約55%,推測維生素C的添加濃度較高,影響細胞株培養液之pH值,進而抑制細胞之生長。From the results of Fig. 2A to Fig. 2F, it was found that a high concentration (100 μM) of peony bark extract was added to HaCaT cell line, B16 cell line, BNL CL.2 cell line and Hs68 cell line to affect the degree of cell growth. Less, the cell survival rate is still maintained above about 70%, so the peony bark extract of Example 1 is not cytotoxic to the above cell lines at the added concentration of up to 100 μM. Next, from the results of the 2C and 2E, it is understood that the higher the concentration of the peony bark extract of the first embodiment added to the HaCaT cell line and the B16 cell line, the higher the cell survival rate of the two cells. In contrast, as can be seen from the results of the 2D graph, the cell survival rate of the high concentration (100 μM) of vitamin C in the BNL CL.2 cell line is only about 55%, and it is presumed that the vitamin C is added at a higher concentration, affecting the cells. The pH of the culture medium of the strain further inhibits the growth of the cells.

實施例三:評估牡丹皮萃取物保護皮膚細胞之能力Example 3: Assessing the ability of the peony bark extract to protect skin cells

此實施例係利用實施例一之牡丹皮萃取物,進一步評估對於經UVB照射後的皮膚細胞之保護能力。This example further evaluated the protective ability of skin cells after UVB irradiation using the peony bark extract of Example 1.

1.建立UVB照射的較適劑量1. Establish a suitable dose of UVB irradiation

首先,將HaCaT細胞株與Hs68細胞株,以1.5×105 /mL之細胞濃度接種於96孔盤中培養24小時後,移除上清液並以PBS潤洗後抽乾。接著,利用不同照射能量(0至1000 J/m2 )之UVB照射上述細胞後,立即於96孔盤之每孔細胞中加入無血清之新鮮培養液培養4小時。然後,利用與實施例二相同之MTT法評估細胞存活率,其結果如第3圖之所示。First, HaCaT cell line and Hs68 cell line were seeded in a 96-well plate at a cell concentration of 1.5 × 10 5 /mL for 24 hours, and the supernatant was removed, rinsed with PBS, and drained. Next, after irradiating the above cells with UVB of different irradiation energies (0 to 1000 J/m 2 ), the serum-free fresh medium was immediately added to the cells of each well of the 96-well plate for 4 hours. Then, the cell survival rate was evaluated by the same MTT method as in Example 2, and the results are shown in Fig. 3.

請參閱第3圖,其係顯示根據本發明一實施例之HaCaT細胞株以及Hs68細胞株經不同能量之UVB照射後的細胞存活率曲線圖,其中橫軸為UVB之照射能量(J/m2 ),縱軸為細胞存活率(%)。Please refer to FIG. 3, which is a graph showing cell survival rate of HaCaT cell line and Hs68 cell line after UVB irradiation with different energies according to an embodiment of the present invention, wherein the horizontal axis is the irradiation energy of UVB (J/m 2 ). ), the vertical axis is the cell survival rate (%).

由第3圖之結果顯示,整體而言,HaCaT細胞較具有抵禦紫外線之能力。其次,HaCaT細胞株與Hs68細胞株利用照射能量10、20 J/m2 之UVB作用後,前述二種細胞之細胞存活率下降至80%左右。然而,利用照射能量50至1000 J/m2 之UVB作用後,細胞存活率隨著照射能量之增加而由70%呈梯度性下降。尤其,利用照射能量150 J/m2 與1000 J/m2 之UVB作用後,前述二種細胞之細胞存活率的差異更為顯著。From the results of Fig. 3, on the whole, HaCaT cells are more resistant to ultraviolet rays. Next, after the HaCaT cell line and the Hs68 cell line were irradiated with UVB of an irradiation energy of 10, 20 J/m 2 , the cell survival rate of the above two kinds of cells was reduced to about 80%. However, after the UVB effect of the irradiation energy of 50 to 1000 J/m 2 , the cell survival rate decreased by 70% as the irradiation energy increased. In particular, after the irradiation energy of 150 J/m 2 and the UVB of 1000 J/m 2 , the difference in cell viability of the above two kinds of cells was more remarkable.

因此,以下係選擇對於HaCaT細胞株與Hs68細胞株較無毒殺作用(存活度≧70%)之UVB照射能量,例如10 J/m2 、20 J/m2 或50 J/m2 ,於存在或不存在牡丹皮萃取物的情況下,根據保護DNA以及促進DNA複製的能力優劣,評估牡丹皮萃取物對於UVB照射後之皮膚細胞的保護能力。Therefore, the following selection of UVB irradiation energy (for survival ≧70%) for HaCaT cell line and Hs68 cell line is, for example, 10 J/m 2 , 20 J/m 2 or 50 J/m 2 in the presence of Or in the absence of the peony bark extract, the ability of the peony bark extract to protect the skin cells after UVB irradiation is evaluated based on the ability to protect the DNA and promote DNA replication.

2.評估(I)-細胞存活率2. Assessment (I) - cell viability

首先,將HaCaT細胞株與Hs68細胞株,以1.5×105 /mL之細胞濃度接種於96孔盤中培養24小時後,移除細胞上清液,更換無血清之新鮮培養液,置於細胞培養箱中培養。培養4小時後,移除上清液並以PBS潤洗後抽乾。接著,利用不同照射能量(10、20、50 J/m2 )之UVB照射或者不照射(即控制組)上述細胞後,立即於96孔盤之每孔細胞中加入無血清之新鮮培養液繼續培養4小時,其中此無血清之培養液係未添加(即UVB控制組,只照射UVB)或添加10 μg/mL或20 μg/mL之實施例一之牡丹皮萃取物(即實驗組,照射UVB後添加牡丹皮萃取物)。然後,利用與實施例二相同之MTT法評估細胞存活率,並於光學顯微鏡影像系統觀察細胞型態之變化,其細胞存活率之結果如第4A圖與第4B圖之所示。First, the HaCaT cell line and the Hs68 cell line were seeded in a 96-well plate at a cell concentration of 1.5 × 10 5 /mL for 24 hours, and then the cell supernatant was removed, and the serum-free fresh medium was replaced and placed in the cell. Culture in an incubator. After 4 hours of culture, the supernatant was removed, rinsed with PBS, and drained. Next, after UVB irradiation with different irradiation energies (10, 20, 50 J/m 2 ) or no irradiation (ie, control group) of the above cells, immediately add serum-free fresh medium to each well of the 96-well plate to continue. Cultured for 4 hours, wherein the serum-free medium was not added (ie, UVB control group, only UVB was irradiated) or 10 μg/mL or 20 μg/mL of the first example of the peony bark extract (ie, experimental group, irradiation) Add peony bark extract after UVB). Then, cell survival rate was evaluated by the same MTT method as in Example 2, and changes in cell type were observed in an optical microscope imaging system, and the results of cell viability were as shown in Figs. 4A and 4B.

請參閱第4A圖與第4B圖,其係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經UVB照射後之HaCaT細胞株以及Hs68細胞株的細胞存活率曲線圖,其中橫軸為不同UVB之照射能量(J/m2 )下使用不同劑量之牡丹皮萃取物,縱軸為細胞存活率(%)。Please refer to FIG. 4A and FIG. 4B, which are graphs showing the cell viability of the peony bark extract of the HaCaT cell line and the Hs68 cell line after UVB irradiation according to Example 1 of several embodiments of the present invention, wherein On the horizontal axis, different doses of peony bark extract were used for different UVB irradiation energies (J/m 2 ), and the vertical axis was cell viability (%).

由第4A圖與第4B圖之結果可知,在使用相同UVB照射能量下,隨著實施例一之牡丹皮萃取物的作用濃度增加,明顯整體提升HaCaT細胞株以及Hs68細胞株的細胞存活率。From the results of Figs. 4A and 4B, it was found that with the same UVB irradiation energy, as the concentration of the effect of the peony bark extract of Example 1 was increased, the cell survival rate of the HaCaT cell line and the Hs68 cell line was significantly increased as a whole.

其次,在UVB控制組中(只照射UVB),隨著UVB照射能量增加,HaCaT細胞株之細胞存活率些微上升,但Hs68 細胞株並無隨著UVB照射能量增加而呈現劑量反應(dose response)。Secondly, in the UVB control group (UVB only), the cell survival rate of HaCaT cell line increased slightly with the increase of UVB irradiation energy, but Hs68 The cell line did not exhibit a dose response as the UVB irradiation energy increased.

再者,在實驗組中(照射UVB後添加50 μM或100 μM實施例一之牡丹皮萃取物),隨著實施例一之牡丹皮萃取物濃度的增加,明顯降低經UVB照射後的HaCaT細胞中所引起之光毒性反應。以UVB照射能量10 J/m2 為例,相較於只經UVB照射之實驗組(UVB照射能量為10 J/m2 ,實施例一之牡丹皮萃取物為0 μM),隨著實施例一之牡丹皮萃取物之作用濃度增加,具明顯提升細胞存活率,如第4A圖之所示。然而,在相同UVB照射能量10 J/m2 之下,實施例一之牡丹皮萃取物於Hs68細胞中之試驗結果並未呈現此一趨勢,如第4B圖所示。因此,以下選擇HaCaT細胞評估實施例一之牡丹皮萃取物之DNA保護及促進DNA複製的能力。Furthermore, in the experimental group (50 μM or 100 μM of the peony bark extract of Example 1 after UVB irradiation), the HaCaT cells after UVB irradiation were significantly reduced as the concentration of the peony bark extract of Example 1 was increased. The phototoxic reaction caused by it. Taking UVB irradiation energy 10 J/m 2 as an example, compared with the experimental group irradiated only by UVB (UVB irradiation energy is 10 J/m 2 , the peony bark extract of Example 1 is 0 μM), with the examples The concentration of the effect of the peony bark extract is increased, which significantly increases the cell survival rate, as shown in Fig. 4A. However, under the same UVB irradiation energy of 10 J/m 2 , the test results of the peony bark extract of Example 1 in Hs68 cells did not exhibit this trend, as shown in Fig. 4B. Therefore, the following HaCaT cells were selected to evaluate the DNA protection of the peony bark extract of Example 1 and the ability to promote DNA replication.

3.評估(II)-彗星試驗3. Evaluation (II) - Comet test

彗星試驗分析法係於螢光顯微鏡下,利用單細胞膠體電泳法(single cell gel electrophoresis;SCGE)直接偵測單一細胞中DNA損傷程度,藉此評估實施例一之牡丹皮萃取物。The comet assay analysis method was performed under a fluorescent microscope, and the degree of DNA damage in a single cell was directly detected by single cell gel electrophoresis (SCGE), thereby evaluating the peony bark extract of Example 1.

首先,將HaCaT細胞株以1.5×105 /mL之密度接種於3 cm2 之培養盤中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮萃取物反應)、UVB控制組(只照射UVB但未與牡丹皮萃取物反應)以及實驗組〔照射UVB前後與50 μM(實驗組I)或100 μM(實驗組II)之牡丹皮萃取物反應4 小時〕。其中,UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射UVB,實驗組於UVB照射前與牡丹皮萃取物反應係用以評估其對於DNA之保護能力,而於UVB照射後再與牡丹皮萃取物反應則用以評估其對於DNA之修復能力。然後,上述各組細胞進行以下單細胞膠體電泳之DNA損傷評估。First, the HaCaT cell strain was seeded at a density of 1.5 × 10 5 /mL in a 3 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peony bark extract), UVB control group (only UVB was irradiated but not reacted with peony bark extract) and experimental group (before and after UVB irradiation with 50 μM) Group I) or 100 μM (experimental group II) of the peony bark extract was reacted for 4 hours]. Among them, the UVB control group and the experimental group were irradiated with UVB under the same conditions as the evaluation (I) of the above Example 3, and the experimental group was reacted with the peony bark extract before UVB irradiation to evaluate its protective ability against DNA. The reaction with the peony bark extract after UVB irradiation was used to evaluate its ability to repair DNA. Then, each of the above groups of cells was subjected to the following DNA damage assessment by single cell colloidal electrophoresis.

上述各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入1 mL之PBS再分散細胞,取其中的100 μL以全自動細胞計數器(例如商品名Countess® automatic cell counter,Invitrogen CountessTM ,)計數細胞密度及存活度,另取500 μl之細胞液與1 μL之溴化乙啶(ethidium bromide;EtBr)混合放置4℃作用5分鐘。接下來,取已塗佈明膠之玻片(FEA,Microscope slides ground edges,厚度1-1.2 mm)滴上300 μl 0.75%一般熔點瓊脂醣(normal melting agarose;NMA),蓋上蓋玻片於4℃放置5分鐘後,取100 μl、體積比1:1之細胞液與0.5%低熔點瓊脂醣(low melting agarose;LMA)的混合物,加至0.75% NMA上,蓋上蓋玻片並於4℃放置5分鐘。然後,再加上100 μl 0.5% LMA,蓋上蓋玻片於4℃放置5分鐘。After the above reaction time was reached, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×). After removing the supernatant by centrifugation, 1 mL of PBS was added to redisperse the cells. 100 μL of the cells were counted for cell density and viability using a fully automated cell counter (eg, the brand name Countess® automatic cell counter, Invitrogen CountessTM ) , and 500 μl of cell fluid and 1 μL of ethidium bromide (ethidium) were taken. Bromide; EtBr) was mixed and allowed to stand at 4 ° C for 5 minutes. Next, apply gelatinized slides (FEA, Microscope slides ground edges, thickness 1-1.2 mm) to 300 μl of 0.75% normal melting agarose (NMA) and cover the coverslip at 4 °C. After standing for 5 minutes, a mixture of 100 μl of a 1:1 volume of cell fluid and 0.5% low melting agarose (LMA) was added to 0.75% NMA, covered with a coverslip and placed at 4 ° C. 5 minutes. Then, add 100 μl of 0.5% LMA, cover with a cover glass and leave at 4 ° C for 5 minutes.

而後,將前述玻片完全浸泡於溶解緩衝溶液(lysing buffer;含2.5 M NaCl,100 mM EDTA,100 Mm Tris-HCl,10% DMSO,1% Triton X100)中,並於4℃放置1小時,使細胞膜破裂。Then, the slide was completely immersed in a lysing buffer (2.5 M NaCl, 100 mM EDTA, 100 Mm Tris-HCl, 10% DMSO, 1% Triton X100) and allowed to stand at 4 ° C for 1 hour. The cell membrane is broken.

然後,前述玻片浸泡於酵素緩衝溶液(enzyme reaction buffer;含40 mM Hepes,0.1 M KCl,0.5mM EDTA,and 0.2 mg/ml BSA,adjusted to pH 8 with KOH)4℃放置15分鐘,以去除細胞膜及核膜等大部份的蛋白質。Then, the aforementioned slide is immersed in an enzyme buffer solution (enzyme reaction) Buffer; containing 40 mM Hepes, 0.1 M KCl, 0.5 mM EDTA, and 0.2 mg/ml BSA, adjusted to pH 8 with KOH) was placed at 4 ° C for 15 minutes to remove most of the protein such as cell membrane and nuclear membrane.

之後,前述玻片再浸泡於鹼性緩衝溶液(alkaline buffer;含0.3M NaOH and 1 mM EDTA in deionized water,pH 13.5)4℃放置15分鐘,使雙股DNA展開形成單股,以增加分析的敏感性。Thereafter, the slides were further immersed in an alkaline buffer solution (alkaline buffer; containing 0.3 M NaOH and 1 mM EDTA in deionized water, pH 13.5) at 4 ° C for 15 minutes to expand the double-stranded DNA to form a single strand to increase the analysis. Sensitivity.

隨後,將前述玻片置於DNA電泳槽中,於4℃且避光的環境下,進行電泳30分鐘後,於螢光顯微鏡(400x)下觀察玻片內細胞的DNA。若細胞DNA產生片斷化等損傷,則斷裂之DNA會移出細胞外而形成拖尾的現象,此時可觀察到DNA具有頭部與尾部,並可觀察到呈現彗星影像。Subsequently, the slide was placed in a DNA electrophoresis tank, and electrophoresis was carried out for 30 minutes at 4 ° C in a dark environment, and the DNA of the cells in the slide was observed under a fluorescence microscope (400 x). If the DNA of the cell is fragmented or the like, the broken DNA will move out of the cell to form a tailing phenomenon. At this time, the DNA has a head and a tail, and a comet image can be observed.

從上述玻片中取相同條件之二重複玻片,各別隨機計數500顆細胞的損傷比例,並隨機取樣25顆呈現彗星型態之細胞進行螢光影像儲存分析。然後,利用市售分析軟體(例如CASP-Comet Assay Software Project,CASPlab),根據頭部長度(head length)、尾部長度(tail length)、頭部亮度(head intensity;或稱頭部DNA量)、尾部亮度(tail intensity;或稱尾部DNA量)等參數,分別計算出頭部DNA百分比{或稱頭部亮度百分比;head DNA intensity(%);即〔頭部亮度/(頭部亮度+尾部亮度)×100〕}、尾部DNA百分比{或稱尾部亮度百分比;tail DNA intensity(%);即〔尾部亮度/(頭部亮度+尾部亮度)×100〕}以及尾動量(tail moment;即(尾部長度×尾部DNA百分比)〕。倘若上述所得之尾部長度百分比、尾部亮度百分比以及尾動量之數值愈 高,表示DNA的損傷愈嚴重,其結果如第5圖之所示。The slides of the same conditions were taken from the above slides, and the damage ratio of 500 cells was randomly counted, and 25 cells with comet-type cells were randomly sampled for fluorescence image storage analysis. Then, using commercially available analytical software (such as CASP-Comet Assay Software Project, CASPlab), according to head length, tail length, head intensity (or head amount of DNA), Parameters such as tail intensity (or tail DNA amount), respectively calculate the percentage of head DNA {or head brightness percentage; head DNA intensity (%); that is, [head brightness / (head brightness + tail brightness) ×100〕}, the percentage of tail DNA {or the percentage of tail brightness; tail DNA intensity (%); that is, [tail brightness / (head brightness + tail brightness) × 100]} and tail moment (tail moment) ×% of tail DNA)). If the above-mentioned percentage of tail length, tail brightness percentage, and tail momentum are more High indicates that the damage of DNA is more serious, and the result is shown in Fig. 5.

請參閱第5圖,其係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經UVB照射後之HaCaT細胞株的彗星試驗照片,其中第5圖之參考線長為50μm。在第5圖中,由上第一行左側起第1張照片代表控制組。由上第一行左側起第2張至第4張照片代表UVB控制組經UVB照射後的結果。由上第二行與第三行照片代表實驗組經UVB照射後的結果。每張照片右上角的方塊係放大顯示該照片隨機取樣之細胞DNA型態。Referring to Fig. 5, there is shown a photograph of a comet assay of a Haca T cell strain after UVB irradiation according to Example 1 of several embodiments of the present invention, wherein the reference line length of Fig. 5 is 50 μm. In Fig. 5, the first picture from the left side of the first line represents the control group. The second to fourth photographs from the left side of the first row represent the results of UVB irradiation in the UVB control group. The results of the second and third rows of photographs represent the results of the experimental group after UVB irradiation. The square in the upper right corner of each photo magnifies the DNA pattern of the cells randomly sampled.

由第5圖結果顯示,隨著UVB照射能量增加,細胞DNA受損而造成的拖尾現象就越顯著,如第5圖UVB控制組(即第一行左側起第2張至第4張照片)所示。其次,隨著實施例一之牡丹皮萃取物的添加量增加,可有效減少DNA損傷所形成的彗星拖尾現象,如第5圖實驗組(即第二行至第三行的照片)所示,證明實施例一之牡丹皮萃取物具保護與修復皮膚細胞的能力。The results from Figure 5 show that as the UVB irradiation energy increases, the tailing phenomenon caused by damage to the cell DNA is more pronounced, as shown in the UVB control group in Figure 5 (ie, the second to fourth photos from the left side of the first line) ) shown. Secondly, with the increase of the addition amount of the peony bark extract of the first embodiment, the comet tailing phenomenon caused by DNA damage can be effectively reduced, as shown in the experimental group of FIG. 5 (ie, the photos of the second row to the third row). It is proved that the peony bark extract of the first embodiment has the ability to protect and repair skin cells.

4.評估(III)-細胞週期4. Assessment (III) - Cell Cycle

此實施例係進一步評估實施例一之牡丹皮萃取物對於細胞週期的影響。概言之,細胞週期分析主要定量分析DNA含量及倍體狀態,利用可穿透細胞膜之螢光染劑〔例如紅色的碘化丙啶(propidium iodide;PI)染劑溶液〕,將染劑分子嵌入DNA分子後,藉由流式細胞儀觀察波長488 nm之紅色螢光強度。當細胞受損或進行凋亡時,DNA會斷裂片斷化而游離於細胞外,此時細胞內嵌入PI的DNA含量則降低,導致相對螢光強度亦減弱,藉此可評估細胞 凋亡程度。This example further evaluates the effect of the peony bark extract of Example 1 on the cell cycle. In summary, cell cycle analysis mainly quantitatively analyzes DNA content and ploidy state, and uses a fluorescent dye that can penetrate cell membranes (such as red propidium iodide (PI) dye solution) to dye the molecule. After embedding the DNA molecule, the red fluorescence intensity at a wavelength of 488 nm was observed by flow cytometry. When the cells are damaged or undergo apoptosis, the DNA is fragmented and released outside the cell. At this time, the DNA content of the cells embedded in the PI is decreased, and the relative fluorescence intensity is also weakened, thereby evaluating the cells. The degree of apoptosis.

首先,HaCaT細胞株與Hs68細胞株係以1.5×105 /mL之密度接種於3 cm2 之培養盤中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮萃取物反應)、UVB控制組(只照射UV但未與牡丹皮萃取物反應)以及實驗組(照射UVB前後均與牡丹皮萃取物反應),其中實驗組於照射UVB前係與50 μM(實驗組I)或100 μM(實驗組II)之牡丹皮萃取物反應4小時,經照射2小時或4小時之UVB後,再與相同濃度之牡丹皮萃取物反應2小時或4小時。First, HaCaT cell line and Hs68 cell line were seeded at a density of 1.5 × 10 5 /mL in a 3 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peony bark extract), UVB control group (only UV was irradiated but not reacted with peony bark extract) and experimental group (both before and after UVB irradiation) Reaction, in which the experimental group was reacted with 50 μM (experimental group I) or 100 μM (experimental group II) of the peony bark extract for 4 hours before UVB irradiation, after UVB for 2 hours or 4 hours, and then The same concentration of the peony bark extract was reacted for 2 hours or 4 hours.

上述各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入300 μl之PBS再分散細胞。接著,緩慢震盪滴入700 μl之99.9%酒精固定細胞,使最終酒精濃度為70%之細胞固定液,置於4℃固定24小時。然後,以1200 rpm之轉速離心5分鐘、移除酒精固定液後,加入445 μL之PBS使細胞均勻分散,再加入5 μL之RNase(10 mg/mL)以及50 μL之10% Triton X-100溶液,於37℃反應30分鐘分解RNA。之後,離心5分鐘、移除上清液後,加入500 μl PBS分散細胞,再加入5 μL之碘化丙啶(propidium iodide;PI)染劑溶液進行DNA染色,置於4℃避光反應15分鐘。隨後,利用0.45 μm之濾膜過濾細胞液並收集於流式細胞分選儀(fluorescence-activated cell sorter;FACS)專用的試管中,使用市售流式細胞分析儀(Flow cytometer),例如FACScanTM 系統(FACScanTM system;Becton Dickson),經由雷射光激發產生之紅色波長螢光(例如參數 設定為FL3 LIN),分析10000顆細胞,配合Winmdi電腦軟體分析細胞週期的分佈,並依細胞週期Sub-G1 、G0 /G1 、S、G2 /M進行數值定量分析,其結果如第6圖所示。After the above reaction time was reached, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×). After removing the supernatant by centrifugation, 300 μl of PBS was added to redisperse the cells. . Next, 700 μl of 99.9% alcohol-fixed cells were slowly shaken, and a cell fixed solution having a final alcohol concentration of 70% was placed and fixed at 4 ° C for 24 hours. Then, centrifuge at 1200 rpm for 5 minutes, remove the alcohol fixative, add 445 μL of PBS to evenly disperse the cells, add 5 μL of RNase (10 mg/mL) and 50 μL of 10% Triton X-100. The solution was reacted at 37 ° C for 30 minutes to decompose RNA. After centrifugation for 5 minutes, remove the supernatant, add 500 μl of PBS to disperse the cells, add 5 μL of propidium iodide (PI) dye solution for DNA staining, and place at 4 ° C in the dark. minute. Subsequently, the cell membrane filter of 0.45 μm and collected in a liquid flow sorter (fluorescence-activated cell sorter; FACS ) dedicated tubes, using a commercially available flow cytometry (Flow cytometer), e.g. FACScan TM System (FACScan TM system; Becton Dickson), red wavelength fluorescence generated by laser excitation (for example, parameter set to FL3 LIN), analysis of 10,000 cells, analysis of cell cycle distribution with Winmdi computer software, and cell cycle Sub- G 1 , G 0 /G 1 , S, and G 2 /M were subjected to numerical quantitative analysis, and the results are shown in Fig. 6.

請參閱第6圖,其係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的細胞週期分佈圖,其中第6圖之橫軸代表時間,而縱軸為細胞對數值。在第6圖中,由上第一行左側起第1張與第二行左側起第1張照片皆顯示控制組的細胞週期分佈圖。由上第一行左側起第2張與第二行左側起第2張照片皆顯示UVB控制組的細胞週期分佈圖。由上第一行左側起第3~4張與第二行左側起第3~4張照片皆顯示實驗組的細胞週期分佈圖。Referring to Figure 6, there is shown a cell cycle distribution of a peony bark extract of HacaT cells irradiated with or without UVB according to Example 1 of several embodiments of the present invention, wherein the horizontal axis of Figure 6 represents Time, while the vertical axis is the cell logarithmic value. In Fig. 6, the first photograph from the left of the first row and the left of the second row shows the cell cycle distribution of the control group. The second cycle from the left of the first row to the left and the second from the left of the second row show the cell cycle distribution of the UVB control group. The cell cycle distribution of the experimental group is shown in the third to fourth photos from the left side of the first line and the third to fourth pictures from the left side of the second line.

由第6圖結果顯示,相較於控制組,UVB控制組細胞在UVB照射後之2小時,其細胞的G0 /G1 期下降,但Sub-G1 和S期增加。UVB照射後之4小時亦有一致的結果,其中UVB控制組細胞在UVB照射後之4小時,其細胞的G0 /G1 期持續下降,但Sub-G1 和G2 /M期亦上升。然而,當實施例一之牡丹皮萃取物加入實驗組細胞後,相較於UVB控制組,實驗組細胞隨著反應時間,顯著提升其S-G2 /M之DNA合成期,但Sub-G1 期則有降低之趨勢,證明實施例一之牡丹皮萃取物確實可影響細胞週期分佈,並提升其S-G2 /M之DNA合成期。The results shown by FIG. 6, compared to the control group, the control group were UVB 2 hours after the UVB irradiation, the cells of the G 0 / G 1 phase decreased, but increased Sub-G 1 and S phase. There was also a consistent result 4 hours after UVB irradiation. In the UVB control group, the G 0 /G 1 phase of the cells continued to decrease 4 hours after UVB irradiation, but the Sub-G 1 and G 2 /M phases also increased. . However, when the peony bark extract of Example 1 was added to the experimental group, compared with the UVB control group, the cells of the experimental group significantly increased the DNA synthesis phase of SG 2 /M with the reaction time, but Sub-G phase 1 There is a tendency to decrease, demonstrating that the peony bark extract of Example 1 does affect cell cycle distribution and enhances the DNA synthesis phase of SG 2 /M.

5.評估(IV)-BrdU免疫螢光染色5. Evaluation (IV)-BrdU immunofluorescence staining

細胞在進行DNA合成時,添加胸腺嘧啶(thymidine)之類似物,例如5-溴脫氧尿嘧啶核苷(5-bromo-deoxy- uridine;BrdU),可造成配對錯誤(misincorporation)而嵌入DNA中,藉此可標定DNA並偵測活細胞中DNA合成的活性。倘若細胞增殖時複製DNA的過程中,可摻入新合成的DNA序列,取代胸腺嘧啶(T),則可藉由BrdU-FITC之螢光含量,偵測化合物是否具細胞增殖作用。When cells are subjected to DNA synthesis, an analog of thymidine, such as 5-bromo-deoxy-nucleoside (5-bromo-deoxy-), is added. Uridine; BrdU), which can cause misincorporation and is embedded in DNA, thereby calibrating DNA and detecting the activity of DNA synthesis in living cells. In the process of replicating DNA during cell proliferation, a newly synthesized DNA sequence can be incorporated to replace thymine (T), and the fluorescence content of BrdU-FITC can be used to detect whether the compound has a cell proliferation effect.

首先,將HaCaT細胞株與Hs68細胞株以1.5×105 /mL之密度,分別接種於96孔盤之每孔中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮萃取物反應)以及多個實驗組(包括照射0、10 J/m2 、20 J/m2 、50 J/m2 之UVB後,分別與0、5 μM、25 μM、50 μM、100 μM之牡丹皮萃取物反應4小時)。上述之UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射UVB。First, HaCaT cell line and Hs68 cell line were seeded at a density of 1.5 × 10 5 /mL, respectively, in each well of a 96-well plate. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peony bark extract) and multiple experimental groups (including UVB with irradiation of 0 , 10 J/m 2 , 20 J/m 2 , 50 J/m 2 ) . Thereafter, it was reacted with 0, 5 μM, 25 μM, 50 μM, 100 μM of peony bark extract for 4 hours). The UVB control group and the experimental group described above were irradiated with UVB under the same conditions as the evaluation (I) of the above Example 3.

上述各組達反應時間後,利用PBS潤洗細胞。接著,於每孔細胞中加入50 μL、100%之冰甲醇(methanol),於4℃反應10分鐘固定細胞。然後,移除上清液並風乾1小時,再加入1%(w/v)之胎牛血清白蛋白(bovine serum albumin;BSA),藉以填補細胞間隙降低非專一性結合所產生的背景值。於室溫下均勻搖晃1小時後,移除上清液,於每孔細胞中加入40 μL之一級抗體,放置4℃反應24小時。一級抗體為抗BrdU之小鼠單株抗體(mouse mAb;Santa Cruz Biotechnology;免疫螢光染色之稀釋濃度為1:100)。After each of the above groups reached the reaction time, the cells were washed with PBS. Next, 50 μL of 100% ice methanol was added to each well of the cells, and the cells were fixed by reacting at 4 ° C for 10 minutes. Then, the supernatant was removed and air-dried for 1 hour, and then 1% (w/v) of bovine serum albumin (BSA) was added to fill the cell gap to reduce the background value produced by non-specific binding. After shaking uniformly for 1 hour at room temperature, the supernatant was removed, and 40 μL of the primary antibody was added to each well of the cells, and allowed to react at 4 ° C for 24 hours. The primary antibody was a monoclonal antibody against mouse BrdU (mouse mAb; Santa Cruz Biotechnology; dilution concentration of immunofluorescence staining was 1:100).

之後,利用PBS清洗細胞二次,加入結合螢光之FITC二級抗體,於室溫下避光反應3小時。而後,利用PBS清洗兩次,於每孔加入100 μL之PBS,以酵素免疫分析儀(BioTek,SynergyTM 2,USA)偵測FITC(Excitation:485 nm, Emission:528 nm)之螢光量;再於每孔加入10 μL、比例1:250的Hoechst 33342染劑溶液(10 μg/mL),均勻混合後,於顯微鏡下觀察細胞核染色。隨後,移除上清液,並於每孔加入100 μL之PBS,利用酵素免疫分析儀(BioTek,SynergyTM 2,USA)偵測Hoechst 33342(Excitation:360 nm,Emission:460 nm)細胞中抗原抗體結合產生之螢光表現,並計算其螢光比例,其結果如第7A圖與第7B圖。Thereafter, the cells were washed twice with PBS, and a FITC secondary antibody that binds to fluorescence was added thereto, and the reaction was allowed to stand at room temperature for 3 hours in the dark. Then, the cells were washed twice with PBS, 100 μL of PBS was added to each well, and the amount of fluorescence of FITC (Excitation: 485 nm, Emission: 528 nm) was detected by an enzyme immunoassay analyzer (BioTek, Synergy TM 2, USA); 10 μL of a 1:250 Hoechst 33342 dye solution (10 μg/mL) was added to each well, and after uniform mixing, nuclear staining was observed under a microscope. Subsequently, the supernatant was removed, and 100 μL of PBS was added to each well, and the antigen in Hoechst 33342 (Excitation: 360 nm, Emission: 460 nm) cells was detected by an enzyme immunoassay analyzer (BioTek, Synergy TM 2, USA). The fluorescence expression produced by antibody binding was calculated and the fluorescence ratio was calculated. The results are shown in Figures 7A and 7B.

請參閱第7A圖與第7B圖,其中第7A圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株與Hs68細胞株的BrdU螢光強度直方圖,而第7B圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於HaCaT細胞株經免疫螢光染色之細胞照片(第7B圖,放大倍率為200倍)。Please refer to FIGS. 7A and 7B, wherein FIG. 7A shows the BrdU firefly of the peony bark extract of HacaT cell line and Hs68 cell line irradiated with or without UVB according to Example 1 of several embodiments of the present invention. Light intensity histogram, and Fig. 7B shows photographs of cells stained with immunofluorescence of HaCaT cell line according to Example 1 of several embodiments of the present invention (Fig. 7B, magnification: 200 times) .

在第7A圖中,上圖為Hs68細胞株的BrdU螢光強度直方圖,下圖為HaCaT細胞株的BrdU螢光強度直方圖,其中橫軸代表控制組與不同條件的實驗組,而縱軸代表不同BrdU螢光強度(%)。In Figure 7A, the upper panel shows the BrdU fluorescence intensity histogram of the Hs68 cell line, and the lower panel shows the BrdU fluorescence intensity histogram of the HaCaT cell line, where the horizontal axis represents the control group and the experimental group with different conditions, while the vertical axis Represents different BrdU fluorescence intensities (%).

在第7B圖中,上起第一行照片為相位差光學顯微鏡觀察到之HaCaT細胞影像,第二行照片為Hoechst 33342螢光染色觀察到之HaCaT細胞核影像,而第三行照片為BrdU螢光染色觀察到之HaCaT細胞株的DNA影像。上起第一排至第三排左側起第1張照片代表控制組。上起第一排至第三排中間照片代表UVB控制組。上起第一排至第三排右側照片代表實驗組。每張照片右下角或右下角的較大方塊係放大顯示較小方塊內隨機取樣之細胞型態。In Figure 7B, the first line of the picture is the HaCaT cell image observed by the phase contrast optical microscope, the second line is the HaCaT cell nuclear image observed by Hoechst 33342 fluorescent staining, and the third line is the BrdU fluorescence. DNA images of HaCaT cell lines observed by staining. The first photo from the first row to the third row from the top represents the control group. The middle photo from the first row to the third row up represents the UVB control group. The photos on the right side of the first row to the third row represent the experimental group. The larger square in the lower right or lower right corner of each photo magnifies the cell pattern randomly sampled within the smaller square.

由第7A圖結果顯示,相較於控制組,隨著UVB照射劑量增加,未與牡丹皮萃取物反應之HaCaT細胞株與HaCaT細胞株的BrdU螢光表現顯著下降。然而,HaCaT細胞經與牡丹皮萃取物反應後,明顯增加BrdU之螢光含量,尤其UVB之照射劑量為10 J/m2 之實驗組中,牡丹皮萃取物明顯提升細胞增殖作用。但是在Hs68細胞株並未觀察到規則的劑量反應(dose response)。From the results of Fig. 7A, the BrdU fluorescence of the HaCaT cell line and the HaCaT cell line which did not react with the peony bark extract was significantly decreased as the UVB irradiation dose was increased as compared with the control group. However, HaCaT cells significantly increased the fluorescence content of BrdU after reacting with the peony bark extract. Especially in the experimental group with UVB irradiation dose of 10 J/m 2 , the peony bark extract significantly enhanced cell proliferation. However, no regular dose response was observed in the Hs68 cell line.

其次,由第7B圖結果顯示,相較於UVB控制組(上起第一排至第三排中間照片),實驗組(上起第一排至第三排右側照片)之HaCaT細胞株因與100 μM之牡丹皮萃取物反應,明顯增加BrdU之螢光含量,證明實施例一之牡丹皮萃取物可促進DNA進行複製,使BrdU-FITC得以嵌入DNA複製之新合成序列中,大幅提升BrdU之螢光表現。Secondly, the results of Figure 7B show that the HaCaT cell line of the experimental group (pictures from the first row to the third row in the upper row) is compared with the UVB control group (the first to third intermediate photos) The 100 μM peony bark extract reacted significantly to increase the fluorescence content of BrdU. It was proved that the peony bark extract of Example 1 can promote DNA replication, allowing BrdU-FITC to be inserted into the new synthetic sequence of DNA replication, greatly enhancing BrdU. Fluorescent performance.

綜上所述,由上述評估(II)-彗星試驗、評估(III)-細胞週期、評估(IV)BrdU免疫螢光染色等實驗證實,實施例一之牡丹皮萃取物確實具有DNA保護以及促進DNA複製的能力。In summary, the above evaluation (II)-comet assay, evaluation (III)-cell cycle, evaluation (IV) BrdU immunofluorescence staining and other experiments confirmed that the peony bark extract of Example 1 does have DNA protection and promotion. The ability to replicate DNA.

實施例四:評估牡丹皮萃取物修復皮膚細胞之能力Example 4: Assessing the ability of peony bark extract to repair skin cells

此實施例係利用實施例一之牡丹皮萃取物,進一步評估對於經UVB照射後的皮膚細胞之修復能力。This example further evaluated the repair ability of skin cells after UVB irradiation using the peony bark extract of Example 1.

1.評估核苷酸切除修復系統之相關基因與蛋白質表現1. Evaluation of related gene and protein expression in nucleotide excision repair system

核苷酸切除修復(NER)系統主要修復因紫外線照射引起之DNA損傷。當細胞進行NER修復DNA時,目前已知先由XPC結合HR23E蛋白質辨識DNA損傷處,再由 TFIIH、XPB和XPD解旋酶使損傷處之DNA鬆散,由XPA和RPA形成複合體結合於DNA損傷處,以促進DNA內切酶XPF/ERCC1剪接5'端和XPG剪切3'端。接著,附著於經剪切之單股DNA上的RPA經CDK2磷酸化後,主要可促進PCNA結合DNA polymerase δ一同填補經切除之DNA損傷片段,進而修復DNA損傷處。The nucleotide excision repair (NER) system primarily repairs DNA damage caused by ultraviolet radiation. When cells perform NER repair DNA, it is known that the DNA damage is identified by XPC combined with HR23E protein. TFIIH, XPB and XPD helicases loosened the DNA at the lesion, and the complex formed by XPA and RPA binds to the DNA damage to promote the endonuclease XPF/ERCC1 splicing 5' end and XPG cleavage 3' end. Subsequently, phosphorylation of RPA attached to the sheared single-stranded DNA by CDK2 mainly promotes the binding of the PCNA-binding DNA polymerase δ to the resected DNA damage fragments, thereby repairing the DNA damage.

首先,將HaCaT細胞株與Hs68細胞株以1.5×105 /mL之密度,分別接種於6孔盤或10 cm2 之培養皿中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮萃取物反應)、UVB控制組(只照射10 J/m2 之UVB但未與牡丹皮萃取物反應)以及實驗組(照射10 J/m2 之UVB前後與牡丹皮萃取物反應)。前述UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射10 J/m2 或50 J/m2 之UVB。實驗組於照射UVB前係與50 μM或100 μM之牡丹皮萃取物反應4小時(控制組則於無血清之新鮮培養液培養4小時),照射UVB,再與相同濃度之牡丹皮萃取物反應2小時、4小時、6小時或8小時(控制組則於無血清之新鮮培養液培養2小時、4小時、6小時)後,測定細胞核苷酸切除修復系統之相關基因與蛋白質表現。First, the HaCaT cell line and the Hs68 cell line were inoculated at a density of 1.5 × 10 5 /mL, respectively, in a 6-well plate or a 10 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peony bark extract), UVB control group (only 10 J/m 2 UVB but not with peony bark extract) and experimental group (irradiation 10) The UVB of J/m 2 reacts with the peony bark extract before and after). The UVB control group and the experimental group were irradiated with UVB of 10 J/m 2 or 50 J/m 2 under the same conditions as the evaluation (I) of the above Example 3. The experimental group was reacted with 50 μM or 100 μM of peony bark extract for 4 hours before irradiation with UVB (the control group was cultured in serum-free fresh medium for 4 hours), irradiated with UVB, and reacted with the same concentration of peony bark extract. After 2 hours, 4 hours, 6 hours or 8 hours (the control group was cultured for 2 hours, 4 hours, and 6 hours in serum-free fresh medium), the related gene and protein expression of the nucleotide excision repair system were measured.

(1)評估NER系統之相關基因表現(1) Assessment of related gene expression in the NER system

上述接種於6孔盤之各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,利用習知方法萃取總RNA。所得之總RNA經定量後,利用同步反轉錄聚合酶鏈鎖反應(real-time reverse-transcription polymerase chain reaction; real-time RT-PCR),檢測實施例一之牡丹皮萃取物是否調控NER系統之相關基因表現。After the above reaction time was inoculated in each of the 6-well plates, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×), and the supernatant was removed by centrifugation. The method is known to extract total RNA. After the total RNA obtained is quantified, a real-time reverse-transcription polymerase chain reaction (real-time reverse-transcription polymerase chain reaction; Real-time RT-PCR) was used to test whether the peony bark extract of Example 1 regulates the related gene expression of the NER system.

上述real-time RT-PCR可參考習知方法或下述方式進行。首先,配製反轉錄反應液,其係利用0.1% DEPC-H2 O將所得之總RNA之濃度調整為2 mg/mL後,將體積補至12.5 μL,並加入1 μL之寡聚胸苷酸〔oligo(dT)〕引子混合均勻,於70℃反應2分鐘。然後,將前述反應混合物迅速置於冰上,再加入4 μL之5倍(5×)莫洛尼氏鼠白血病病毒(moloney murine leukemia virus;MMLV)之反轉錄反應緩衝溶液(MMLV-RT buffer solution)、1 μL之10 mM dNTPs、0.5 μL之核醣核酸酶抑制劑(RNase inhibitor)以及1 μL之MMLV反轉錄酶(MMLV RTase),於42℃反應1小時並於94℃反應5分鐘,以合成cDNA。之後,加入冰的二次去離子水(ddH2 O)將cDNA的體積補足至100 μL,即製備完成cDNA並存放於-80℃。The above real-time RT-PCR can be carried out by referring to a conventional method or the following manner. First, a reverse transcription reaction solution was prepared which adjusted the concentration of the total RNA obtained to 2 mg/mL with 0.1% DEPC-H 2 O, and the volume was made up to 12.5 μL, and 1 μL of oligo-thymidylate was added. [oligo (dT)] The primer was uniformly mixed and reacted at 70 ° C for 2 minutes. Then, the above reaction mixture was quickly placed on ice, and then 4 μL of 5 times (5×) Moloney murine leukemia virus (MMLV) reverse transcription reaction buffer solution (MMLV-RT buffer solution) was added. 1 μL of 10 mM dNTPs, 0.5 μL of RNase inhibitor and 1 μL of MMLV reverse transcriptase (MMLV RTase), reacted at 42 ° C for 1 hour and reacted at 94 ° C for 5 minutes to synthesize cDNA. Thereafter, the volume of cDNA was made up to 100 μL by adding iced deionized water (ddH 2 O), and the cDNA was prepared and stored at -80 °C.

接下來,取上述10 μL之cDNA(約10 ng至50 ng),與12.5 μL之SYBR Green混合物、2.5 μl 10 μM之各基因引子對混合物(包括上游引子與上游引子)以及ddH2 O,混合為總體積25μL之反應溶液。前述各基因適用的上游引子與上游引子之具體例如第1表之所示: Next, take the above 10 μL of cDNA (about 10 ng to 50 ng), mix with 12.5 μL of SYBR Green mixture, 2.5 μl of 10 μM gene primer pair (including upstream primer and upstream primer) and ddH 2 O. A total volume of 25 μL of the reaction solution. Specific examples of the upstream primer and the upstream primer for each of the aforementioned genes are shown in Table 1, for example:

上述反應溶液經低轉速離心後,進行同步定量PCR(real-time quantitative PCR),其反應條件如下:於95℃進行15秒使雙股模板DNA分離(ds DNA denaturation),於52℃至60℃進行45秒使引子黏合(annealing),於72℃進行1分鐘使DNA延長反應(extension),以此為一個循環,共重複進行40個循環的反應,然後於72℃進行5分鐘。待循環完畢,利用市售軟體,例如amplification plot或其他功能替代的軟體,分析上述所得NER系統之相關基因的螢光強度,其結果如第8A圖之所示。After the above reaction solution was centrifuged at a low rotation speed, real-time quantitative PCR was carried out under the following conditions: separation of the double-stranded template DNA (dDNA denaturation) at 52 ° C for 15 seconds at 52 ° C to 60 ° C The primer was annealed for 45 seconds, and the DNA was extended at 72 ° C for 1 minute to carry out an extension of the DNA, and the reaction was repeated for 40 cycles, and then carried out at 72 ° C for 5 minutes. After the cycle is completed, the fluorescence intensity of the gene related to the NER system obtained above is analyzed using a commercially available software such as an amplification plot or other functional replacement software, and the results are shown in Fig. 8A.

請參閱第8A圖,其係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關基因表現,其中橫軸為HaCaT細胞株與牡丹皮萃取物反應的時間(小時),縱軸為NER系統之相關基因相對於β-肌動蛋白之基因表現量(density ratio;由螢光強度換算而得)。Please refer to FIG. 8A, which shows the related gene expression of the nucleotide excision repair system (NER) of the Haca T cell line with or without UVB irradiation according to Example 1 of several embodiments of the present invention. , wherein the horizontal axis is the time (hours) of the reaction between the HaCaT cell line and the peony bark extract, and the vertical axis is the gene expression of the NER system related gene relative to β-actin (density ratio; converted from fluorescence intensity) ).

由第8A圖之結果顯示,相較於控制組,HaCaT細胞株在照射UVB前先與50 μM之牡丹皮萃取物反應4小時、且在照射UVB後又與50 μM之牡丹皮萃取物反應2小時,可明顯增加其XPC基因的表現量。至於其他基因,例如 XPA基因、RPA基因、ERCC1基因、XPF基因、XPG基因及PCNA基因,其表現量亦隨著反應時間增加而增加,顯示實施例一之牡丹皮萃取物確實可增加NER系統相關的基因表現量,有助於修復HaCaT細胞經紫外線照射後造成的DNA損傷。From the results of Fig. 8A, the HaCaT cell line was reacted with 50 μM of peony bark extract for 4 hours before irradiation with UVB, and reacted with 50 μM of peony bark extract after irradiation with UVB. Hours can significantly increase the amount of XPC gene expression. As for other genes, for example The expression levels of XPA gene, RPA gene, ERCC1 gene, XPF gene, XPG gene and PCNA gene also increased with the increase of reaction time, indicating that the peony peel extract of Example 1 can increase the gene expression related to the NER system. Helps to repair DNA damage caused by UV irradiation of HaCaT cells.

(2)評估NER系統之相關蛋白質表現(I)(2) Evaluation of related protein performance of NER system (I)

(2.1)萃取蛋白質(2.1) Extracting proteins

將上述10 cm2 之培養皿各組(實驗組為照射10 J/m2 之UVB後再與相同濃度之牡丹皮萃取物反應8小時)達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,進行蛋白質萃取,以西方墨點法分析相關蛋白表現。After the reaction time was reached in each of the above 10 cm 2 culture dishes (the experimental group was irradiated with 10 J/m 2 of UVB and then reacted with the same concentration of the peony bark extract for 8 hours), the supernatant was separately collected to 15 mL for centrifugation. The tube was removed by trypsin (1×), and the supernatant was removed by centrifugation, followed by protein extraction, and the protein expression was analyzed by Western blotting.

首先,可運用習知方法,利用不同濃度的BSA建立標準曲線,再將上述萃取而得之蛋白質的吸光值帶入線性回歸公式,換算出各組的蛋白質濃度。本發明所述之技術領域中具有通常知識者應可熟知建立標準曲線並換算蛋白質濃度,在此不另贅述。First, a standard curve can be established using different concentrations of BSA using a conventional method, and the absorbance of the extracted protein can be brought into a linear regression formula to convert the protein concentration of each group. Those of ordinary skill in the art to which the present invention pertains should be familiar with establishing standard curves and converting protein concentrations, which are not described herein.

(2.2)蛋白質電泳分析(2.2) Protein electrophoresis analysis

接下來,上述各組的蛋白質可利用十二烷基硫酸鈉-聚丙烯醯胺膠體電泳分析(SDS-PAGE electrophoresis assay)進行評估。首先,根據第2表製備10%之下層膠(Running gel)並注入製膠器中,膠體上層加入蒸餾水以壓平膠體液面,待凝固後移除上層之ddH2 O並吸乾殘存水份。Next, the proteins of the above groups can be evaluated using a sodium dodecyl sulfate-polyacrylamide colloidal electrophoresis assay (SDS-PAGE electrophoresis assay). First, 10% of the running gel was prepared according to the second table and injected into the gluer. Distilled water was added to the upper layer of the colloid to flatten the colloidal liquid surface. After solidification, the upper layer of ddH 2 O was removed and the remaining moisture was absorbed. .

然後,根據第3表製備7.5%上層膠(stacking gel),注入下層膠上方後,再插入齒模,待凝固後移除齒模即完成。Then, 7.5% of a stacking gel was prepared according to the third table, and after being injected into the lower layer of the underlayer, the tooth mold was inserted, and the tooth mold was removed after solidification.

隨後,取上述各組的蛋白質經換算後,與5×Loading dye buffer以5:1之體積比混合,於100℃處理5分鐘後,移至4℃冷卻備用。Subsequently, the proteins of the above groups were converted, mixed with 5× Loading dye buffer in a volume ratio of 5:1, treated at 100 ° C for 5 minutes, and then moved to 4 ° C for cooling.

將上述製備好的膠片放入市售電泳槽(例如商品名miniVE,Complete,GE-80-6418-77,GE Healthcare,.U.S.A.)中,以90伏特之電壓預跑15分鐘至20分鐘。然後,依序加入標準蛋白分子量標記(standard protein MW marker)以及上述各組的蛋白質後,以130伏特之電壓進行電泳分析。The film prepared above was placed in a commercially available electrophoresis tank (for example, trade name miniVE, Complete, GE-80-6418-77, GE Healthcare, .U.S.A.), and pre-run for 15 minutes to 20 minutes at a voltage of 90 volts. Then, a standard protein MW marker and a protein of each of the above groups were sequentially added, followed by electrophoresis analysis at a voltage of 130 volts.

然後,將上述SDS-PAGE之電泳膠體取下,進行西方轉漬法分析(Western blotting assay)。首先,將市售轉印膜,例如聚偏二氟乙烯轉印膜(polyvinylidene difluoride membrans,PVDF membrane;例如商品名PolyScreen PVDF Hybridization Transfer Membrane,PK-NEF1002,PerkinElmer,U.S.A.)浸泡於甲醇5分鐘,以改變PVDF membrane之極性。接下來,於組合卡匣(Gel holder cassette)中依序放上海綿墊、濾紙以及電泳膠體,再覆蓋PVDF轉印膜,清除其中之氣泡後,再依序放上濾紙、海綿墊並將卡匣蓋上夾緊,置入市售西方轉漬槽(例如商品名Mighty small transphor,TE 22,Amersham biosciences,U.S.A.)中,以60伏特之電壓、200毫安培、於4℃下進行轉漬90分鐘,將蛋白質轉印至PVDF轉印膜上。之後,將經轉漬完成帶有蛋白質之PVDF轉印膜利用0.1% PBST(Tween-20/PBS)清洗後,即進行特定蛋白質表現之免疫染色。Then, the above-mentioned SDS-PAGE electrophoresis colloid was taken out and subjected to Western blotting assay. First, a commercially available transfer film such as polyvinylidene difluoride membrans (PVDF membrane; for example, the trade name PolyScreen PVDF) Hybridization Transfer Membrane, PK-NEF1002, PerkinElmer, U.S.A.) was soaked in methanol for 5 minutes to change the polarity of the PVDF membrane. Next, put the sponge pad, filter paper and electrophoresis gel in the Gel holder cassette, cover the PVDF transfer film, remove the bubbles, and then put the filter paper, sponge pad and card in sequence. The crucible is clamped and placed in a commercially available western transfer tank (for example, trade name Mighty small transphor, TE 22, Amersham biosciences, USA), and subjected to 60 volts at a voltage of 200 volts at 4 ° C. Minutes, the protein was transferred to a PVDF transfer film. Thereafter, the PVDF transfer film with protein was completely washed with 0.1% PBST (Tween-20/PBS), and immunostaining of specific protein expression was performed.

上述轉漬完成之PVDF轉印膜浸泡於含有5%脫脂奶粉之0.1% PBST(Tween-20/PBS)中,輕微搖晃作用60分鐘,以進行非特異性抗原阻斷(non-specific antigen blocking)。接著,以0.1% PBST清洗PVDF轉印膜後,利用0.1% PBST配製一級抗體(1:1000),將PVDF轉印膜完全浸泡於一級抗體於4℃下反應至隔夜。然後,再以0.1% PBST清洗PVDF轉印膜,並加入二級抗體(1:1000)於4℃下作用2-3小時。之後,於4℃以0.1% PBST清洗PVDF轉印膜2小時,加入呈色劑與PVDF轉印膜反應3分鐘。而後,再加入顯色劑混合反應,隨即利用冷光影像分析儀(Avegene Life Science,LIAS ChemLite Series,ChemLite 200FA/400FA)儲存影像。前述之冷光影像分析儀可根據儲存的影像,偵測Luminol(Cyclic phthalhydrazides)由基態被 激發成激發態、再回復到基態時釋出冷光的強度,並進行定量分析。The above-mentioned PVDF transfer film was immersed in 0.1% PBST (Tween-20/PBS) containing 5% skim milk powder and shaken gently for 60 minutes for non-specific antigen blocking. . Next, after washing the PVDF transfer film with 0.1% PBST, the primary antibody (1:1000) was prepared using 0.1% PBST, and the PVDF transfer film was completely immersed in the primary antibody and reacted at 4 ° C until overnight. Then, the PVDF transfer film was washed with 0.1% PBST, and a secondary antibody (1:1000) was added thereto to act at 4 ° C for 2-3 hours. Thereafter, the PVDF transfer film was washed with 0.1% PBST at 4 ° C for 2 hours, and a coloring agent was added to react with the PVDF transfer film for 3 minutes. Then, a color developer mixing reaction was added, and images were stored using a cold light image analyzer (Avegene Life Science, LIAS ChemLite Series, ChemLite 200FA/400FA). The aforementioned luminescence image analyzer can detect Luminol (Cyclic phthalhydrazides) from the ground state according to the stored image. The intensity of luminescence is released when excited into an excited state and then returned to the ground state, and quantitative analysis is performed.

請參閱第8B圖,其係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白質表現的西方轉漬法分析圖,其中第1道表示控制組NER相關蛋白質的表現量,第2道表示UVB控制組NER相關蛋白質的表現量,第3道表示實驗組NER相關蛋白質的表現量,其中實施例係於UVB照射前與50 μM之牡丹皮萃取物反應4小時,且於10 J/m2 之UVB照射後再與相同濃度之牡丹皮萃取物反應8小時。Please refer to FIG. 8B, which shows the protein expression of the nucleotide excision repair system (NER) of the Haca T cell line with or without UVB irradiation according to Example 1 of several embodiments of the present invention. The Western blotting analysis chart, in which the first track represents the performance of the NER-related protein in the control group, the second track represents the performance of the NER-related protein in the UVB control group, and the third track represents the performance of the NER-related protein in the experimental group, wherein The examples were reacted with 50 μM of peony bark extract for 4 hours before UVB irradiation, and reacted with the same concentration of peony bark extract for 8 hours after UVB irradiation at 10 J/m 2 .

由第8B圖之結果可知,相較於UVB控制組,實驗組之HaCaT細胞株在照射UVB前先與50 μM之牡丹皮萃取物反應4小時、且在照射UVB後又與50 μM之牡丹皮萃取物反應8小時後,可提升XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA之表現量。As can be seen from the results of Fig. 8B, compared with the UVB control group, the HaCaT cell line of the experimental group was reacted with 50 μM of the peony bark extract for 4 hours before irradiation with UVB, and 50 μM of peony bark after irradiation with UVB. After 8 hours of reaction, the expression of XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA can be increased.

(3)評估NER系統之相關蛋白質表現(II)(3) Assessment of related protein expression in the NER system (II)

上述各組(實驗組為照射50 J/m2 之UVB後再與相同濃度之牡丹皮萃取物反應4小時)達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入500 μL之4%三聚甲醛(paraformaldehyde)於4℃反應1小時固定細胞並分析相關蛋白質表現。接著,加入5 μL之10% Triton X-100於4℃作用5分鐘後,進行離心去除上清液,加入一級抗體於4℃反應24小時。然後,加入FITC二級抗體(1:500)避光於室 溫下反應3小時。隨後,將細胞液移至FACS專用的試管中,使用流式細胞分析儀,經由雷射光激發產生之綠色波長螢光(FL1 LOG)分析10000顆細胞,配合Winmdi電腦軟體來分析經化合物作用後,各種蛋白之螢光表現量並進行定量,其結果如第8C圖之所示。After the reaction time was reached in each of the above groups (the experimental group was irradiated with 50 J/m 2 of UVB and then reacted with the same concentration of peony bark extract for 4 hours), the supernatant was separately collected into a 15 mL centrifuge tube, and trypsin was used again. Trypsin, 1×) Remove the cells, remove the supernatant by centrifugation, add 500 μL of 4% paraformaldehyde at 4 ° C for 1 hour to fix the cells and analyze the protein expression. Next, 5 μL of 10% Triton X-100 was added and the mixture was allowed to act at 4 ° C for 5 minutes, and then the supernatant was removed by centrifugation, and the primary antibody was added and reacted at 4 ° C for 24 hours. Then, FITC secondary antibody (1:500) was added to avoid light and react at room temperature for 3 hours. Subsequently, the cell liquid was transferred to a FACS-dedicated test tube, and 10,000 cells were analyzed by a green wavelength fluorescence (FL1 LOG) generated by laser light excitation using a flow cytometer, and analyzed by the Winmdi computer software after the action of the compound. The amount of fluorescent expression of various proteins was quantified, and the results are shown in Fig. 8C.

上述適用的一級抗體之具體例可如第4表所示: Specific examples of the above applicable primary antibodies can be as shown in Table 4:

請參閱第8C圖,其係顯示根據本發明數個實施例之利用流式細胞分析儀實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白表現的三維直方圖,其中x軸代表螢光強度,y軸代表不同組別,z軸代表細胞數。y軸由近到遠分別為第1道至第5道,其中第1道表示陰性控制組(未經UVB照射之HaCaT細胞株)NER相關蛋白質的表現量,第2道表示控制組NER相關蛋白質的表現量,第3道表示UVB控制組NER相關蛋白質的表現量,第4道表示實驗組I(與50 μM之牡丹皮萃取物反應)NER相關蛋白質的表現量,第5道表示實驗組II(與100 μM之牡丹皮萃取物反應)NER相 關蛋白質的表現量。Please refer to FIG. 8C, which shows a nucleotide excision repair system for the HaCaT cell line with or without UVB irradiation using the peony bark extract of Example 1 of the flow cytometer according to several embodiments of the present invention. A three-dimensional histogram of the related protein representation of NER), where the x-axis represents the fluorescence intensity, the y-axis represents the different groups, and the z-axis represents the number of cells. The y-axis is from the first to the fifth, respectively, from the first to the fifth, wherein the first lane represents the expression of the NER-related protein in the negative control group (HaCaT cell line not irradiated with UVB), and the second lane represents the NER-related protein in the control group. The amount of performance, the third track represents the performance of the NER-related protein in the UVB control group, and the fourth track represents the performance of the NER-related protein in the experimental group I (reacted with 50 μM of the peony bark extract), and the fifth track represents the experimental group II. (Reacts with 100 μM of Cortex Extract) NER Phase The amount of protein expression.

由第8C圖可知,相較於控制組,UVB控制組於UVB(50 J/m2 )作用4小時後,其XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA之表現降低。然而,實驗組之蛋白質表現卻隨著牡丹皮萃取物反應濃度增加而明顯提升,證實實施例一之牡丹皮萃取物可藉由提升NER相關蛋白之表現量,修復經紫外線照射後HaCaT細胞DNA之受損處。As can be seen from Fig. 8C, the performance of XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA was decreased in the UVB control group after UVB (50 J/m 2 ) for 4 hours compared with the control group. However, the protein performance of the experimental group increased significantly with the increase of the reaction concentration of the peony bark extract. It was confirmed that the peony bark extract of Example 1 can repair the DNA of HaCaT cells after ultraviolet irradiation by increasing the expression of NER-related protein. Damaged place.

上述結果顯示實施例一之牡丹皮萃取物可提升NER相關基因之DNA與蛋白質合成,進而促進細胞修復。The above results show that the peony bark extract of Example 1 can enhance the DNA and protein synthesis of NER-related genes, thereby promoting cell repair.

實施例五:評估牡丹皮萃取物修復活體皮膚細胞之能力Example 5: Assessing the ability of peony bark extract to repair living skin cells

此實施例係利用實施例一之牡丹皮萃取物製備成凝膠以塗抹於活體皮膚,進一步評估其對於經UVB照射後的皮膚細胞之修復能力。This example was prepared by using the peony bark extract of Example 1 to prepare a gel for application to living skin, and further evaluating its ability to repair skin cells after UVB irradiation.

首先,製備牡丹皮萃取物凝膠,其係將實施例一之牡丹皮萃取物配置為100 μM之濃度,各取10 μL加入於各自欲分散之1 mL生理食鹽水中,秤取2 g之羥乙基纖維素(hydroxyethyl cellulose;HEC)凝膠加入並使其完全溶解,利用封口蠟膜(parafilm)封口避光,經24小時使膠體增稠凝集,以製得牡丹皮萃取物凝膠(含2%之HEC與20 μg/mL之牡丹皮萃取物)備用。First, a peony bark extract gel was prepared, and the peony bark extract of Example 1 was set to a concentration of 100 μM, and 10 μL of each was added to 1 mL of physiological saline to be dispersed, and 2 g of hydroxyl was weighed. Ethyl cellulose (HEC) gel was added and completely dissolved, sealed with a parafilm seal to protect the light, and the colloid was thickened and agglomerated over 24 hours to prepare a peony bark extract gel (including 2% HEC and 20 μg/mL of peony bark extract) were used.

同時,製備安慰劑,其係將2 g之HEC凝膠溶解於1 mL之生理食鹽水(pH值調整為6.47),利用封口蠟膜封口,經24小時使膠體增稠凝集,以製得安慰劑(含2%之HEC)備 用。At the same time, placebo was prepared by dissolving 2 g of HEC gel in 1 mL of physiological saline (pH adjusted to 6.47), sealing with a sealing wax film, and thickening and aggregating the colloid over 24 hours to make a comfort. Agent (including 2% HEC) use.

另外,將30隻C57BL/6JNarl品系5週大之公鼠(購自國科會動物實驗中心),以每5隻為一籠,飼養於具空調恆溫之動物飼養房中,其中飼養溫度保持在21±2℃、溼度保持在50%至60%並維持12小時切換之光暗循環。飼養期間不限制飼料及水的供應,其餘飼養條件均依循國家衛生研究院公告的相關實驗動物管理指南進行。待小鼠適應實驗環境一週後進行實驗(6週大),所有組別實驗過程皆在白天亮燈情況下進行。進行實驗前,先將小鼠背部脫毛放置24小時,每隻小鼠秤量體重後,進行腹腔麻醉注射(1 g/10 μl),將30隻小鼠依下述各組別進行處理。In addition, 30 C57BL/6JNarl strains of 5-week-old male rats (purchased from the National Animal Research Center of the National Science Association) were housed in a cage with 5 air conditioners in an air-conditioned animal house, in which the feeding temperature was maintained. 21 ± 2 ° C, humidity maintained at 50% to 60% and maintained a 12-hour switching light dark cycle. The feed and water supply are not restricted during the feeding period, and the remaining feeding conditions are carried out in accordance with the relevant experimental animal management guidelines announced by the National Institutes of Health. The mice were subjected to an experiment (6 weeks old) after one week of adaptation to the experimental environment, and all the experimental procedures were performed during daylighting. Before the experiment, the mice were depilated for 24 hours, and each mouse was weighed and administered with abdominal anesthesia (1 g/10 μl), and 30 mice were treated according to the following groups.

控制組係隨機取5隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,不進行任何UVB照射及藥物處理,並於0、2、4、6、8小時之時間點,以色差計各別時間點測定L、a、b值,並同時進行皮膚組織之鑽孔切片(punch)。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。Five mice were randomly selected from the control group, and the L, a, and b values of each mouse were recorded by skin colorimeter, without any UVB irradiation and drug treatment, and at 0, 2, 4, 6, and 8 hours. Point, the L, a, b values were measured at different time points of the color difference meter, and the punching of the skin tissue was simultaneously performed. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

安慰劑控制組係隨機取5隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,每隻塗抹0.05 g的安慰劑但不進行任何UVB照射,並於0、2、4、6、8小時之時間點,以色差計測定L、a、b值,並同時進行皮膚組織之鑽孔切片(punch)。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。In the placebo-controlled group, 5 mice were randomly selected, and the L, a, and b values of each mouse were recorded by a skin color difference meter, each of which applied 0.05 g of placebo without any UVB irradiation, and at 0, 2, At 4, 6 and 8 hours, the L, a, and b values were measured with a color difference meter, and a punch of the skin tissue was simultaneously performed. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

塗抹安慰劑之UVB控制組係隨機取5隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,經脫毛後每隻小鼠 於照射部位,每隻塗抹0.05 g的安慰劑作用4小時,進行UVB(2000 J/m2 )照射後,使用皮膚色差計測量記錄每隻小鼠L、a、b值。然後,於每隻小鼠於照射部位再塗抹0.05 g的安慰劑,各別測定與紀錄0、2、4、6、8小時之L、a、b值。隨後,於照射部位進行皮膚組織之鑽孔切片。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。Five mice were randomly selected from the placebo-treated UVB control group. The L, a, and b values of each mouse were recorded by skin colorimeter. After depilation, each mouse was given a 0.05 g consolation at each irradiation site. The agent was allowed to act for 4 hours, and after UVB (2000 J/m 2 ) irradiation, the L, a, and b values of each mouse were recorded using a skin color difference meter. Then, 0.05 g of placebo was applied to each of the mice at the irradiation site, and the L, a, and b values were recorded and recorded for 0, 2, 4, 6, and 8 hours, respectively. Subsequently, a drilled section of the skin tissue is performed at the irradiation site. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

實驗組係隨機取15隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,隨機分配塗抹化合物組各5隻實驗小鼠,經脫毛後每隻小鼠於照射部位,每隻塗抹0.05 g的牡丹皮萃取物凝膠,反應4小時。然後,進行UVB(2000 J/m2 )照射,以皮膚色差計測量記錄每隻小鼠於0小時、2小時、4小時、6小時、8小時之L、a、b值,並於各小鼠之照射部位再次塗抹0.05 g的牡丹皮萃取物凝膠。之後,以皮膚色差計測量記錄於0小時、2小時、4小時、6小時、8小時之L、a、b值。隨後,於照射部位進行皮膚組織之鑽孔切片。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於10%中性福馬林溶液(neutral formalin solution)中儲存於4℃。In the experimental group, 15 mice were randomly selected, and the L, a, and b values of each mouse were recorded by skin color difference meter. Five experimental mice in each group of the smearing compound were randomly distributed. After depilation, each mouse was irradiated. Each of the 0.05 g of the peony bark extract gel was applied and reacted for 4 hours. Then, UVB (2000 J/m 2 ) irradiation was performed, and L, a, and b values of each mouse at 0 hours, 2 hours, 4 hours, 6 hours, and 8 hours were recorded and measured by a skin color difference meter, and each small A 0.05 g layer of peony bark extract was applied again to the irradiated area of the mouse. Thereafter, L, a, and b values recorded at 0 hours, 2 hours, 4 hours, 6 hours, and 8 hours were measured with a skin color difference meter. Subsequently, a drilled section of the skin tissue is performed at the irradiation site. The epidermis layer of the removed skin tissue was stained with red medicinal water and immersed in a 10% neutral formalin solution and stored at 4 °C.

前述浸泡於4%三聚甲醛以及10%中性福馬林溶液中的皮膚組織,隨後進行石蠟包埋,使液態石蠟逐漸取代組織中的水分。之後,將前述包埋盒於4℃約10分鐘使石蠟凝集,再放置於冷凍櫃增加石蠟硬度,以進行石蠟組織切片。所得之石蠟組織切片進一步利用蘇木紫-伊紅(hematoxylin-eosin;H&E)染色,藉此觀察細胞組織的形態 結構是否產生變化,其結果如第9A圖之所示。上述之石蠟包埋、組織切片、H&E染色等應為本發明所屬技術領域中具有通常知識者所熟知,此處不再贅述。The aforementioned skin tissue soaked in 4% paraformaldehyde and 10% neutral formalin solution is subsequently paraffin-embedded to gradually replace the water in the tissue with liquid paraffin. Thereafter, the embedded cassette was agglutinated at 4 ° C for about 10 minutes, and then placed in a freezer to increase the paraffin hardness to perform paraffin tissue sectioning. The obtained paraffin tissue sections were further stained with hematoxylin-eosin (H&E) to observe the morphology of the cell tissues. Whether the structure changes or not, the result is as shown in Fig. 9A. The paraffin embedding, tissue sectioning, H&E staining and the like described above are well known to those of ordinary skill in the art to which the present invention pertains, and are not described herein.

另外,上述組織切片可進一步進行免疫組織化學染色(IHC)分析,其係利用螢光素異硫氰酸鹽(fluorescein isothiocyanate;FITC)標定之抗體進行原位染色,以專一性偵測組織切片中之NER相關蛋白並予以定位。簡言之,上述石蠟組織切片經脫蠟、水化後,浸泡於3% H2 O2 於4℃作用20分鐘,再以PBS清洗後,浸泡於檸檬酸緩衝溶液中,利用微波爐以4 W加熱3分鐘後,隨即更換冷的檸檬酸緩衝溶液並於4℃冷卻15分鐘,再利用微波爐以4 W加熱2分鐘。前述組織切片利用1×PBS清洗5分鐘後,加入阻隔緩衝液(blocking buffer)反應30分鐘,以填補組織間隙。然後,於組織切片滴上如第4表所示之一級抗體(1:100),於室溫處理2小時後,依序以PBS清洗組織兩次,再浸泡於PBST處理10分鐘,最後以清水清洗30分鐘。之後,於組織切片滴上二級抗體(1:500),避光於室溫下反應2小時後,依序以PBS清組織胞兩次,再浸泡於PBST處理30分鐘。而後,於顯微鏡下觀察FITC螢光染色情形,再於組織滴上以1:250之比例的Hoechst 33342 staining solution(10 μg/ml)作用10分鐘,於顯微鏡下觀察組織細胞以及染色情形,其結果如第9B圖至第9I圖之「細胞核」所示。然後,利用PBS清洗細胞兩次,滴上封片膠蓋上蓋玻片,利用透明指甲油固定蓋玻片邊緣附著於載玻片上,於顯微鏡下進行螢光影像攝影分析,其結果如第9B圖至第 9I圖之NER相關蛋白螢光染色所示。In addition, the above tissue sections can be further subjected to immunohistochemical staining (IHC) analysis, which is in situ stained with an antibody calibrated with fluorescein isothiocyanate (FITC) to specifically detect tissue sections. NER related proteins and localized. Briefly, the paraffin tissue sections were dewaxed and hydrated, soaked in 3% H 2 O 2 at 4 ° C for 20 minutes, washed with PBS, immersed in citric acid buffer solution, and microwaved at 4 W. After heating for 3 minutes, the cold citric acid buffer solution was replaced and cooled at 4 ° C for 15 minutes, and then heated in a microwave oven at 4 W for 2 minutes. The tissue sections were washed with 1×PBS for 5 minutes, and then reacted by adding a blocking buffer for 30 minutes to fill the interstitial space. Then, one-stage antibody (1:100) as shown in Table 4 was dropped on the tissue section, and after treatment at room temperature for 2 hours, the tissue was washed twice with PBS, then immersed in PBST for 10 minutes, and finally with water. Wash for 30 minutes. Thereafter, secondary antibody (1:500) was dropped on the tissue section, and the reaction was allowed to stand at room temperature for 2 hours in the dark, and then the cells were incubated twice with PBS, and then immersed in PBST for 30 minutes. Then, the FITC fluorescence staining was observed under a microscope, and Hoekst 33342 staining solution (10 μg/ml) at a ratio of 1:250 was applied to the tissue for 10 minutes, and the tissue cells and staining were observed under a microscope. As shown in the "nuclei" of Figures 9B to 9I. Then, the cells were washed twice with PBS, and the coverslips were covered with a cover gel, and the edges of the coverslips were fixed on the slides with transparent nail polish, and fluorescence imaging analysis was performed under a microscope. The results are shown in Fig. 9B. Fluorescent staining of the NER-related protein to Figure 9I is shown.

請參閱第9A圖至第9I圖,其係顯示根據本發明數個實施例之利用實施例一之牡丹皮萃取物製備的凝膠塗抹於活體皮膚之組織化學染色結果。由第9A圖之H&E stain之結果顯示,僅塗抹安慰劑之UVB控制組的表皮層稍顯增厚,但利用牡丹皮萃取物凝膠塗抹之實驗組的組織較完整。其次,由第9B圖之BrdU結果顯示,BrdU表現量隨著牡丹皮萃取物凝膠之反應時間增加而增加。再著,由第9C圖至第9I圖之結果顯示,NER相關蛋白經化合物(1)、(2)作用後XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA等NER相關蛋白之表現量隨著牡丹皮萃取物凝膠之反應時間增加而增加,證實實施例一之牡丹皮萃取物可藉由提升NER相關蛋白之表現量,修復經紫外線照射後活體皮膚細胞DNA之受損處。Referring to Figs. 9A to 9I, there are shown results of histochemical staining of a gel prepared by using the peony bark extract of Example 1 on a living skin according to several embodiments of the present invention. From the results of H&E stain in Fig. 9A, the epidermal layer of the UVB control group applied only with placebo was slightly thickened, but the tissue of the experimental group coated with the peony bark extract was relatively complete. Secondly, the BrdU results from Fig. 9B show that the amount of BrdU expression increases as the reaction time of the peony bark extract gel increases. Furthermore, the results from Fig. 9C to Fig. 9I show that the expression of NER-related proteins such as XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA by NER-related proteins after compound (1) and (2) The reaction time of the peony bark extract gel increased, and it was confirmed that the peony bark extract of the first embodiment can repair the damage of the DNA of the living skin cells after ultraviolet irradiation by increasing the expression of the NER-related protein.

實施例六:評估牡丹皮萃取物保護DNA抗氧化之能力Example 6: Assessing the ability of peony bark extract to protect DNA from oxidation

1.建立H1. Establish H 22 OO 22 與UVB處理的較適劑量Suitable dose with UVB treatment

皮膚細胞經由外界紫外線輻射照射或進行生理代謝均會引起氧化性壓力,造成DNA損傷。此實施例係利用不同濃度之H2 O2 及/或不同能量之UVB照射下,經由光解作用後形成之羥基自由基,攻擊質體DNA,藉此模擬自由基對DNA的傷害,進一步評估實施例一之牡丹皮萃取物對於保護DNA抗氧化之能力。Skin cells that are exposed to ultraviolet radiation or physiological metabolism can cause oxidative stress and cause DNA damage. This embodiment uses different concentrations of H 2 O 2 and/or UVB irradiation of different energies to attack the plastid DNA via photodegradation of hydroxyl radicals, thereby simulating the damage of DNA by free radicals. The ability of the peony bark extract of Example 1 to protect DNA against oxidation.

首先,取pUC119質體DNA(0.5 μg/μL;Takara,Japan)與DNA分子量標準標記(DNA MW standard marker;經N-Hind III切割,以下簡稱λHind III標記;0.5 μg/μL; Takara,Japan),二者分別利用8倍體積的PBS稀釋後,依下述各組別進行處理。First, pUC119 plastid DNA (0.5 μg/μL; Takara, Japan) and DNA molecular weight standard marker (DNA MW standard marker; N-Hind III cleavage, hereinafter referred to as λHind III label; 0.5 μg / μL; Takara, Japan), after dilution with 8 volumes of PBS, respectively, was treated according to the following groups.

控制組係分別取2 μL經PBS稀釋後之pUC119質體DNA(0.056 μg/μL)或2 μL經PBS稀釋後之λHind III標記(0.056 μg/μL),分別加入8 μL之PBS後,二者利用瓊脂凝膠進行核酸電泳分析。2 μL of pUC119 plastid DNA (0.056 μg/μL) diluted with PBS or 2 μL of λHind III labeled (0.056 μg/μL) diluted with PBS were added to the control group, respectively, and 8 μL of PBS was added. Nucleic acid electrophoresis analysis was performed using an agar gel.

對照組係取2 μL之上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL),加入6.5 μL之ddH2 O、1 μL之限制酶反應溶液(H buffer)以及0.5μL之限制酶EcoRI(15 unit/μL;Takara,Japan),於37℃作用1小時後,利用瓊脂凝膠進行核酸電泳分析。In the control group, 2 μL of the above pUC119 plastid DNA (0.056 μg/μL) diluted with PBS was added, and 6.5 μL of ddH 2 O, 1 μL of restriction enzyme reaction solution (H buffer) and 0.5 μL of restriction enzyme EcoRI were added. (15 unit/μL; Takara, Japan), after 1 hour of action at 37 ° C, nucleic acid electrophoresis analysis was performed using an agar gel.

H2 O2 與UVB處理組係將上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL)或λHind III標記(0.056 μg/μL),各別取2 μL加入3 μL之PBS和5 μL之H2 O2 (濃度分別為5 mM、10 mM、20 mM、30 mM、40 mM)。接著,pUC119 DNA Plasmid照射10 J/m2 、20 J/m2 、50 J/m2 、100 J/m2 、200 J/m2 之UVB,而λHind III標記則照射1000 J/m2 、2000 J/m2 、3000 J/m2 、3500 J/m2 、4000 J/m2 之UVB後,二者利用瓊脂凝膠進行核酸電泳分析。The H 2 O 2 and UVB treatment groups were treated with pUC119 plastid DNA (0.056 μg/μL) or λHind III (0.056 μg/μL) diluted with PBS, and 2 μL of each was added to 3 μL of PBS and 5 μL. H 2 O 2 (concentrations of 5 mM, 10 mM, 20 mM, 30 mM, 40 mM, respectively). Next, the pUC119 DNA Plasmid was irradiated with UVB of 10 J/m 2 , 20 J/m 2 , 50 J/m 2 , 100 J/m 2 , and 200 J/m 2 , and the λ Hind III label was irradiated with 1000 J/m 2 , After UVB of 2000 J/m 2 , 3000 J/m 2 , 3500 J/m 2 , and 4000 J/m 2 , the two were subjected to nucleic acid electrophoresis analysis using an agar gel.

上述核酸電泳係使用濃度0.8%之瓊脂凝膠進行電泳30分鐘。然後,利用影像擷取分析系統拍下電泳膠片並進行影像分析,以控制組之DNA色帶濃度為100%,分別計算出各組之超螺旋(supercoil;SC)型DNA、開環(open circular;OC)型DNA以及線型(linear;LN)DNA之百分比(%)。The above nucleic acid electrophoresis was carried out by electrophoresis using a 0.8% agar gel for 30 minutes. Then, using the image capture analysis system to take the electrophoretic film and perform image analysis, the DNA ribbon concentration of the control group is 100%, and the supercoil (SC) type DNA and open loop (open circular) of each group are respectively calculated. OC) type DNA and percentage (%) of linear (LN) DNA.

一般而言,pUC119質體DNA主要原為超螺旋(supercoil;SC)結構(圖未繪示),經EcoRI 限制內切酶處理後,可將pUC119質體DNA剪切成線型(LN)結構(圖未繪示)。當pUC119質體DNA暴露於5 mM之H2 O2 且UVB照射能量達200 J/m2 時,亦可將質體DNA完全剪切成線型(LN)結構,如第10A圖H2 O2 與UVB處理組之UVB 200 J/m2 的色帶所示。隨著H2 O2 濃度愈高,將pUC119質體DNA完全剪切成線型(LN)結構所需的UVB照射能量就愈低。當pUC119質體DNA暴露於40 mM之H2 O2 時,將pUC119質體DNA完全剪切成線型(LN)結構所需的UVB照射能量,與暴露於20 mM之H2 O2 時所需的UVB照射能量十分相近(圖未繪示)。In general, pUC119 plastid DNA is mainly supercoil (SC) structure (not shown), and after treatment with EcoRI restriction endonuclease, pUC119 plastid DNA can be cut into linear (LN) structure ( The figure is not shown). When the pUC119 plastid DNA is exposed to 5 mM H 2 O 2 and the UVB irradiation energy reaches 200 J/m 2 , the plastid DNA can also be completely sheared into a linear (LN) structure, such as Figure 10A H 2 O 2 . and UVB UVB treated group of 200 J / m 2 of the ink ribbon shown in FIG. The higher the concentration of H 2 O 2 , the lower the UVB irradiation energy required to completely shear the pUC119 plastid DNA into a linear (LN) structure. When the pUC119 plastid DNA is exposed to 40 mM H 2 O 2 , the UVB irradiation energy required to completely cleave pUC119 plastid DNA into a linear (LN) structure is required for exposure to 20 mM H 2 O 2 The UVB irradiation energy is very similar (not shown).

DNA線型片段亦可獲得類似的結果,以λHind III標記為例,其包括多種不同分子量之DNA線型片段,隨著UVB照射能量的增加,DNA片段之損傷就越嚴重。當λHind III標記暴露於5 mM之H2 O2 且UVB照射能量達3500 J/m2 時,可將λHind III DNA剪切成較碎小的片段(圖未繪示)。隨著H2 O2 濃度愈高,將λHind III DNA剪切成較碎小片段所需的UVB照射能量就愈低(圖未繪示)。Similar results were obtained for DNA linear fragments, exemplified by the λHind III label, which includes DNA linear fragments of various molecular weights, and the damage of the DNA fragments is more severe as the energy of UVB irradiation increases. When the λHind III label is exposed to 5 mM H 2 O 2 and the UVB irradiation energy reaches 3500 J/m 2 , the λHind III DNA can be cut into smaller fragments (not shown). As the H 2 O 2 concentration is higher, the UVB irradiation energy required to shear the λHind III DNA into smaller fragments is lower (not shown).

根據上述結果,以下係選擇將pUC119質體DNA與λHind III DNA分別暴露於5 mM與20 mM之H2 O2 時,並分別利用照射劑量200 J/m2 以及3500 J/m2 之UVB進行照射,藉此評估實施例一之牡丹皮萃取物是否可保護DNA抗氧化且避免DNA損傷。Based on the above results, the following selection was performed to expose pUC119 plastid DNA and λHind III DNA to 5 mM and 20 mM H 2 O 2 , respectively, and to use UVB at an irradiation dose of 200 J/m 2 and 3500 J/m 2 , respectively. Irradiation, thereby evaluating whether the peony bark extract of Example 1 can protect DNA from oxidation and avoid DNA damage.

2.評估牡丹皮萃取物保護DNA抗氧化且避免DNA損2. Evaluation of peony bark extract to protect DNA from oxidation and avoid DNA damage 傷的能力Injury ability

此實施例先於pUC119質體DNA或λHind III DNA中加入50 μM或100 μM實施例一之牡丹皮萃取物,再藉由UVB照射與H2 O2 誘導,將pUC119質體DNA或λHind III DNA分別暴露於5 mM與20 mM之H2 O2 ,再分別利用照射劑量200 J/m2 以及3500 J/m2 之UVB進行照射,然後利用上述評估方法確認牡丹皮萃取物是否可保護DNA抗氧化且避免DNA損傷。此處評估的控制組、對照組、H2 O2 與UVB處理組、H2 O2 與UVB處理方法與核酸電泳分析與本實施例六第1例相同,此處不作贅言。In this example, 50 μM or 100 μM of the peony bark extract of Example 1 was added to pUC119 plastid DNA or λHind III DNA, and then induced by UVB irradiation and H 2 O 2 to induce pUC119 plastid DNA or λHind III DNA. were exposed to H 2 O 2 5 mM and 20 mM, the irradiation dose and then were 200 J / m 2 and 3500 J / m UVB 2 of irradiated, and then verify that extracts of Paeonia protected by the above evaluation method of anti-DNA Oxidize and avoid DNA damage. The control group, the control group, the H 2 O 2 and UVB treatment groups evaluated here, the H 2 O 2 and UVB treatment methods, and the nucleic acid electrophoresis analysis are the same as those in the first embodiment of the sixth embodiment, and no rumors are made here.

至於實驗組I係取2 μL上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL),加入3 μL實施例一之牡丹皮萃取物(濃度50 μM或100 μM),再各別和5 μL之H2 O2 (5 mM或20 mM)混合後,照射UVB(200 J/m2 ),再利用瓊脂凝膠進行核酸電泳分析。For the experimental group I, take 2 μL of the above-mentioned pUC119 plastid DNA diluted with PBS (0.056 μg/μL), and add 3 μL of the peony bark extract of Example 1 (concentration: 50 μM or 100 μM), and then separately and 5 After mixing μL of H 2 O 2 (5 mM or 20 mM), UVB (200 J/m 2 ) was irradiated, and nucleic acid electrophoresis analysis was performed using an agar gel.

另外,實驗組II則取2 μL上述經PBS稀釋後之λHind III標記(0.056 μg/μL),加入3 μL實施例一之牡丹皮萃取物(濃度50 μM或100 μM),再各別和5 μL之H2 O2 (5 mM或20 mM)混合後,照射UVB(200 J/m2 ),再利用瓊脂凝膠進行核酸電泳分析。上述結果如第10A圖至第10B圖所示。In addition, in the experimental group II, 2 μL of the above-mentioned λHind III labeled (0.056 μg/μL) diluted with PBS was added, and 3 μL of the peony bark extract of Example 1 (concentration of 50 μM or 100 μM) was added, and then each and 5 After mixing μL of H 2 O 2 (5 mM or 20 mM), UVB (200 J/m 2 ) was irradiated, and nucleic acid electrophoresis analysis was performed using an agar gel. The above results are shown in Figures 10A to 10B.

請參閱第10A圖至第10B圖,其係顯示根據本發明數個實施例之利用實施例一之牡丹皮萃取物對於保護DNA抗氧化之核酸電泳圖,其中第10A圖係顯示pUC119質體DNA經不同濃度之H2 O2 及/或不同能量之UVB處理後之核酸電泳圖,而第10B圖則顯示λHind III標記經不同濃度 之H2 O2 及/或不同能量之UVB處理後之核酸電泳圖。Please refer to FIG. 10A to FIG. 10B, which are diagrams showing the electrophoresis of nucleic acid against the oxidation of DNA by using the peony bark extract of the first embodiment according to several embodiments of the present invention, wherein the 10A map shows the pUC119 plastid DNA. The nucleic acid electrophoresis pattern after treatment with different concentrations of H 2 O 2 and/or UVB of different energies, and the 10B graph shows that the λHind III labeling nucleic acid treated with different concentrations of H 2 O 2 and/or different energy UVB Electropherogram.

由第10A圖至第10B之核酸電泳圖的結果顯示,pUC119質體DNA主要原為超螺旋(SC)結構(如第10A圖之控制組所示),經EcoRI 限制內切酶處理後,可將pUC119質體DNA剪切成線型(LN)結構(如第10A圖之對照組所示)。當pUC119質體DNA先加入實施例一之牡丹皮萃取物後,再暴露於5 mM或20 mM之H2 O2 且UVB照射能量達200 J/m2 時,50 μM或100 μM牡丹皮萃取物可有效保護且避免大部分的質體DNA不被剪切成線型(LN)結構,如第10A圖之實驗組I的色帶所示。The results of the nucleic acid electrophoresis patterns from 10A to 10B show that the pUC119 plastid DNA is mainly a supercoiled (SC) structure (as shown in the control group of Fig. 10A), and after treatment with EcoRI restriction endonuclease, The pUC119 plastid DNA was cut into a linear (LN) structure (as shown in the control group of Figure 10A). When pUC119 plastid DNA was first added to the peony bark extract of Example 1, and then exposed to 5 mM or 20 mM H 2 O 2 and UVB irradiation energy up to 200 J/m 2 , 50 μM or 100 μM peony bark extract The material is effectively protected and prevents most of the plastid DNA from being sheared into a linear (LN) structure, as shown by the band of experimental group I in Figure 10A.

第10B圖亦可獲得類似的結果。由第10B圖之核酸電泳圖的結果顯示,當λHind III標記暴露於5 mM或20 mM之H2 O2 且UVB照射能量達3500 J/m2 時,可將λHind III DNA剪切成較碎小的片段,如第10B圖之實驗組II的色帶所示。當λHind III標記先加入實施例一之牡丹皮萃取物後,再暴露於5 mM或20 mM之H2 O2 且UVB照射能量達3500 J/m2 時,50 μM或100 μM牡丹皮萃取物可有效保護且避免大部分的λHind III標記不被剪切成較碎小的片段,如第10B圖之實驗組II的色帶所示。Similar results can be obtained with Figure 10B. The results of the electropherogram of the nucleic acid of Figure 10B show that when the λHind III label is exposed to 5 mM or 20 mM H 2 O 2 and the UVB irradiation energy reaches 3500 J/m 2 , the λHind III DNA can be cut into smaller pieces. Small fragments are shown in the ribbon of Experiment Group II in Figure 10B. When the λHind III label was added to the peony bark extract of Example 1 and then exposed to 5 mM or 20 mM H 2 O 2 and the UVB irradiation energy reached 3500 J/m 2 , 50 μM or 100 μM peony bark extract It is effective to protect and avoid most of the λHind III label from being cut into smaller fragments, as shown by the ribbon of Experiment Group II in Figure 10B.

綜合以上實施例結果,實施例一之牡丹皮萃取物不僅具抑制黑色素生成、促使DNA複製及調控NER修復機制,更可有效預防及保護DNA避免因H2 O2 與UVB照射而引發損傷。Based on the results of the above examples, the peony bark extract of Example 1 not only inhibits melanin production, promotes DNA replication, and regulates the NER repair mechanism, but also effectively prevents and protects DNA from damage caused by H 2 O 2 and UVB irradiation.

需補充的是,本發明雖以特定的製程條件、特定細胞株、特定分析方法或特定儀器為例示,說明本發明之牡丹 皮萃取物及其製造方法之應用,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之牡丹皮萃取物可使用其他製程條件、其他細胞株、其他分析方法或儀器進行。此外,本發明所得之牡丹皮萃取物以及第一萃取物應用於化妝品組合物時,其形式可包括但不限於水劑、乳劑、膏劑、粉劑、美白劑、淡斑劑、袪斑劑或上述任意組合之化妝品。再者,本發明所得之牡丹皮萃取物應用於食品添加物時,其形式可包括但不限於營養品或保健食品。It should be noted that although the present invention is exemplified by specific process conditions, specific cell strains, specific analytical methods or specific instruments, the peony of the present invention is illustrated. The application of the skin extract and the method of producing the same, but it is to be understood by those skilled in the art that the present invention is not limited thereto, and the peony bark extract of the present invention may be used without departing from the spirit and scope of the present invention. Use other process conditions, other cell lines, other analytical methods or instruments. In addition, when the peony bark extract and the first extract obtained by the present invention are applied to a cosmetic composition, the form thereof may include, but not limited to, a liquid, an emulsion, an ointment, a powder, a whitening agent, a spotting agent, a freckle agent, or the like. Any combination of cosmetics. Furthermore, when the peony bark extract obtained by the present invention is applied to a food additive, its form may include, but is not limited to, a nutraceutical or a health food.

由上述本發明實施例可知,本發明之牡丹皮萃取物及其製造方法,其優點在於利用至少一分配萃取步驟以及至少一管柱分離步驟,可有效獲得苯乙酮類化合物之牡丹皮萃取物,以提供DNA修復、抑制黑色素生成以及抗氧化的生物活性。由於利用本發明之苯乙酮類化合物之牡丹皮萃取物兼具多種生物活性,故所得之牡丹皮萃取物可應用於化妝品組合物及/或食品添加物。It can be seen from the above embodiments of the present invention that the peony bark extract and the method for producing the same have the advantages that the peony ketone extract can be effectively obtained by using at least one partitioning extraction step and at least one column separation step. To provide DNA repair, inhibition of melanin production, and antioxidant biological activity. Since the peony skin extract using the acetophenone compound of the present invention has various biological activities, the obtained peony bark extract can be applied to a cosmetic composition and/or a food additive.

雖然本發明已以數個實施例揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。While the invention has been described above in terms of several embodiments, it is not intended to limit the scope of the invention, and the invention may be practiced in various embodiments without departing from the spirit and scope of the invention. The scope of protection of the present invention is defined by the scope of the appended claims.

100‧‧‧方法100‧‧‧ method

101‧‧‧提供牡丹皮材料之步驟101‧‧‧Procedures for providing peony skin material

103‧‧‧利用第一有機溶液對牡丹皮材料進行粗萃取步驟,以獲得粗萃物之步驟103‧‧‧Steps of crude extraction of the peony bark material using the first organic solution to obtain the crude extract

105‧‧‧利用第二有機溶液對粗萃物進行第一分配萃取步驟,以獲得第一萃取物之步驟105‧‧‧Step of performing a first partition extraction step on the crude extract using the second organic solution to obtain the first extract

107‧‧‧利用第三有機水溶液對第一萃取物進行第二分配萃取 步驟,以獲得第二萃取物之步驟107‧‧‧Second partition extraction of the first extract using a third aqueous organic solution Step to obtain the second extract step

109‧‧‧對第二萃取物進行第一管柱分離步驟,以獲得第一溶離液與第二溶離液之步驟109‧‧‧Steps of performing a first column separation step on the second extract to obtain a first solution and a second solution

111‧‧‧對第二溶離液進行第二管柱分離步驟,以分離出牡丹皮萃取物之步驟111‧‧‧Steps of separating the second eluate into a second column separation step to separate the cortex peel extract

為讓本發明之上述和其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之詳細說明如下:The above and other objects, features, advantages and embodiments of the present invention will become more apparent and understood.

第1圖係繪示根據本發明一實施例之牡丹皮萃取物之製程流程圖。BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a flow chart showing the process of extracting a peony bark according to an embodiment of the present invention.

第2A圖至第2F圖係顯示根據本發明數個實施例之HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株與實施例一之牡丹皮萃取物或維生素C作用72小時後的細胞存活率曲線圖。2A to 2F are diagrams showing the HaCaT cell strain, the B16 cell strain, the BNL CL.2 cell strain, and the Hs68 cell strain according to several embodiments of the present invention, and the cortex peel extract or vitamin C of Example 1 for 72 hours. Post-cell survival rate graph.

第3圖係顯示根據本發明一實施例之HaCaT細胞株以及Hs68細胞株經不同能量之UVB照射後的細胞存活率曲線圖。Fig. 3 is a graph showing cell survival rate of HaCaT cell line and Hs68 cell line after UVB irradiation with different energies according to an embodiment of the present invention.

第4A圖與第4B圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經UVB照射後之HaCaT細胞株以及Hs68細胞株的細胞存活率曲線圖。Fig. 4A and Fig. 4B are graphs showing the cell viability of the peony bark extract of the HacaT cell line and the Hs68 cell line after UVB irradiation according to Example 1 of several examples of the present invention.

第5圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經UVB照射後之HaCaT細胞株的彗星試驗照片。Fig. 5 is a photograph showing a comet assay of a Haca T cell strain after UVB irradiation according to Example 1 of several examples of the present invention.

第6圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的細胞週期分佈圖。Fig. 6 is a graph showing the cell cycle distribution of the peony bark extract of HahaT cells irradiated with or without UVB according to Example 1 of several embodiments of the present invention.

第7A圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株與Hs68細胞株的BrdU螢光強度直方圖。Fig. 7A is a BrdU fluorescence intensity histogram showing the HacaT cell line and the Hs68 cell line irradiated with or without UVB according to Example 1 of several examples of the present invention.

第7B圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於HaCaT細胞株經免疫螢光染色之細胞照片(第7B圖,放大倍率為200倍)。Fig. 7B is a photograph showing the cells of the peony bark extract subjected to immunofluorescence staining of the HaCaT cell line according to Example 1 of several embodiments of the present invention (Fig. 7B, magnification: 200 times).

第8A圖係顯示根據本發明數個實施例之實施例一之 牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關基因表現。Figure 8A shows an embodiment 1 according to several embodiments of the present invention. The peony bark extract is expressed for the gene related to the nucleotide excision repair system (NER) of the HaCaT cell line irradiated with or without UVB.

第8B圖係顯示根據本發明數個實施例之實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白質表現的西方轉漬法分析圖。Figure 8B is a diagram showing the Western blotting of the protein expression of the nucleotide excision repair system (NER) of the HacaT cell line with or without UVB irradiation according to Example 1 of several embodiments of the present invention. Method analysis chart.

第8C圖係顯示根據本發明數個實施例之利用流式細胞分析儀實施例一之牡丹皮萃取物對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白表現的三維直方圖。Figure 8C shows the correlation of the nucleoside excision repair system (NER) of the HacaT cell line with or without UVB irradiation using the flow cytometry sample of Example 1 in accordance with several embodiments of the present invention. A three-dimensional histogram of protein expression.

第9A圖至第9I圖係顯示根據本發明數個實施例之利用實施例一之牡丹皮萃取物製備的凝膠塗抹於活體皮膚之組織化學染色結果。Fig. 9A to Fig. 9I show the results of histochemical staining of a gel prepared by using the peony bark extract of Example 1 on a living skin according to several embodiments of the present invention.

第10A圖至第10B圖係顯示根據本發明數個實施例之利用實施例一之牡丹皮萃取物對於保護DNA抗氧化之核酸電泳圖。10A to 10B are diagrams showing the electrophoresis of nucleic acids for protecting DNA against oxidation of the peony bark extract of Example 1 according to several embodiments of the present invention.

<110> 嘉南藥理科技大學<120> 牡丹皮萃取物及其製造方法暨應用<130> 無<160> 16 <210> 1 <211> 17 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(XPC F) <400> 1<210> 2 <211> 26 <212> DNA <213> 人工序列<220> primer <223> PCR reverse primer(XPC R) <400> 2<210> 3 <211> 20 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(XPA F) <400> 3<210> 4 <211> 22 <212> DNA <213> 人工序列 <220> primer <223> PCR reverse primer(XPA R) <400> 4<210> 5 <211> 20 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(RPA F) <400> 5<210> 6 <211> 20 <212> DNA <213> 人工序列<220> primer <223> PCR reverse primer(RPA R) <400> 6<210> 7 <211> 19 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(ERCC1 F) <400> 7<210> 8 <211> 21 <212> DNA <213> 人工序列 <220> primer <223> PCR reverse primer(ERCC1 R) <400> 8<210> 9 <211> 18 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(XPF(ERCC4) F) <400> 9<210> 10 <211> 23 <212> DNA <213> 人工序列<220> primer <223> PCR reverse primer(XPF(ERCC4) R) <400> 10<210> 11 <211> 17 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(XPG(ERCC5) F) <400> 11<210> 12 <211> 25 <212> DNA <213> 人工序列 <220> primer <223> PCR reverse primer(XPG(ERCC5) R) <400> 12<210> 13 <211> 24 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(PCNA F) <400> 13<210> 14 <211> 26 <212> DNA <213> 人工序列<220> primer <223> PCR reverse primer(PCNA R) <400> 14<210> 15 <211> 20 <212> DNA <213> 人工序列<220> primer <223> PCR forward primer(β -actin F) <400> 15<210> 16 <211> 17 <212> DNA <213> 人工序列 <220> primer <223> PCR reverse primer(β -actin R) <400> 16 <110> Jianan University of Pharmacy <120> Cortex peel extract and its manufacturing method and application <130> None <160> 16 <210> 1 <211> 17 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( XPC F) <400> 1 <210> 2 <211> 26 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( XPC R) <400> 2 <210> 3 <211> 20 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( XPA F) <400> 3 <210> 4 <211> 22 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( XPA R) <400> 4 <210> 5 <211> 20 <212> DNA <213> Artificial Sequence <220> primer <223> PCR forward primer( RPA F) <400> 5 <210> 6 <211> 20 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( RPA R) <400> 6 <210> 7 <211> 19 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( ERCC1 F) <400> 7 <210> 8 <211> 21 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( ERCC1 R) <400> 8 <210> 9 <211> 18 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( XPF(ERCC4) F) <400> 9 <210> 10 <211> 23 <212> DNA <213> Artificial Sequence <220> primer <223> PCR reverse primer( XPF(ERCC4) R) <400> 10 <210> 11 <211> 17 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( XPG(ERCC5) F) <400> 11 <210> 12 <211> 25 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( XPG(ERCC5) R) <400> 12 <210> 13 <211> 24 <212> DNA <213> Artificial Sequence <220> primer <223> PCR forward primer( PCNA F) <400> 13 <210> 14 <211> 26 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( PCNA R) <400> 14 <210> 15 <211> 20 <212> DNA <213> Artificial sequence <220> primer <223> PCR forward primer( β - actin F) <400> 15 <210> 16 <211> 17 <212> DNA <213> Artificial sequence <220> primer <223> PCR reverse primer( β - actin R) <400> 16

100‧‧‧方法100‧‧‧ method

101‧‧‧提供牡丹皮材料之步驟101‧‧‧Procedures for providing peony skin material

103‧‧‧利用第一有機溶液對牡丹皮材料進行粗萃取步驟,以獲得粗萃物之步驟103‧‧‧Steps of crude extraction of the peony bark material using the first organic solution to obtain the crude extract

105‧‧‧利用第二有機溶液對粗萃物進行第一分配萃取步驟,以獲得第一萃取物之步驟105‧‧‧Step of performing a first partition extraction step on the crude extract using the second organic solution to obtain the first extract

107‧‧‧利用第三有機水溶液對第一萃取物進行第二分配萃取步驟,以獲得第二萃取物之步驟107‧‧‧Step of performing a second partitioning extraction step on the first extract with a third organic aqueous solution to obtain a second extract

109‧‧‧對第二萃取物進行第一管柱分離步驟,以獲得第一溶離液與第二溶離液之步驟109‧‧‧Steps of performing a first column separation step on the second extract to obtain a first solution and a second solution

111‧‧‧對第二溶離液進行第二管柱分離步驟,以分離出牡丹皮萃取物之步驟111‧‧‧Steps of separating the second eluate into a second column separation step to separate the cortex peel extract

Claims (5)

一種於體外處理動物細胞之方法,其特徵在於利用含有一有效劑量50μM至100μM之2,5-二羥基-4-甲基苯乙酮的一組成物於體外處理一動物細胞,該2,5-二羥基-4-甲基苯乙酮如式(I)所示之2,5-二羥基-4-甲基苯乙酮: 且該2,5-二羥基-4-甲基苯乙酮具DNA修復的生物活性,以於體外修復該動物細胞之DNA。A method for treating animal cells in vitro, characterized in that an animal cell is treated in vitro using a composition comprising an effective dose of 50 μM to 100 μM of 2,5-dihydroxy-4-methylacetophenone, the 2,5 -Dihydroxy-4-methylacetophenone such as 2,5-dihydroxy-4-methylacetophenone of formula (I): And the 2,5-dihydroxy-4-methylacetophenone has the biological activity of DNA repair to repair the DNA of the animal cell in vitro. 根據申請專利範圍第1項所述之於體外處理動物細胞之方法,其中該組成物為一化妝品組合物。 A method for treating animal cells in vitro according to the invention of claim 1, wherein the composition is a cosmetic composition. 根據申請專利範圍第1項所述之於體外處理動物細胞之方法,其中該組成物為一食品組成物。 A method of treating an animal cell in vitro according to the first aspect of the invention, wherein the composition is a food composition. 根據申請專利範圍第1項所述之於體外處理動物細胞之方法,其中該動物細胞之一來源為人類或小鼠。 A method for treating animal cells in vitro according to the invention of claim 1, wherein one of the animal cells is derived from human or mouse. 根據申請專利範圍第1項所述之於體外處理動物 細胞之方法,其中該動物細胞為一皮膚細胞、一黑色素細胞或一肝細胞。 Treatment of animals in vitro according to the scope of claim 1 A method of cells, wherein the animal cell is a skin cell, a melanocyte or a hepatocyte.
TW101128457A 2012-08-07 2012-08-07 Extract of peony root cortex, method of preparing the same and application thereof TWI480047B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101128457A TWI480047B (en) 2012-08-07 2012-08-07 Extract of peony root cortex, method of preparing the same and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101128457A TWI480047B (en) 2012-08-07 2012-08-07 Extract of peony root cortex, method of preparing the same and application thereof

Publications (2)

Publication Number Publication Date
TW201406386A TW201406386A (en) 2014-02-16
TWI480047B true TWI480047B (en) 2015-04-11

Family

ID=50550255

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101128457A TWI480047B (en) 2012-08-07 2012-08-07 Extract of peony root cortex, method of preparing the same and application thereof

Country Status (1)

Country Link
TW (1) TWI480047B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108330156A (en) * 2018-03-26 2018-07-27 上海数儒生物科技有限公司 A kind of big white orchid growing point extract safety detecting method
CN113546112B (en) * 2021-07-26 2022-10-04 山西纳安健康科技有限公司 Method for extracting phenolic compounds from peony leaves and roots in classification manner

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周俊兆,中藥牡丹皮在化粧品之生物活性研究,嘉南藥理科技大學化粧品科技研究所 碩士論文,2007年公開 林清宮, 中草藥資源開發應用-抗氧化活性篩選, 嘉南藥理科技大學專題研究計畫成果報告, 2009年 *

Also Published As

Publication number Publication date
TW201406386A (en) 2014-02-16

Similar Documents

Publication Publication Date Title
Takatani et al. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome
Kim et al. The chromene sargachromanol E inhibits ultraviolet A‐induced ageing of skin in human dermal fibroblasts
JP5872158B2 (en) Skin whitening method and screening method for skin spot formation inhibition and / or removal factor
Klepac et al. Effects of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes
Lin et al. Optimal conditions for cordycepin production in surface liquid-cultured Cordyceps militaris treated with porcine liver extracts for suppression of oral cancer
Bona et al. Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme
Singh et al. Attenuation of diethylnitrosamine (DEN)–Induced hepatic cancer in experimental model of Wistar rats by Carissa carandas embedded silver nanoparticles
Lajis et al. Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: Evidence from in vitro study
Stefanowicz-Hajduk et al. Securinine from Phyllanthus glaucus induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells
Tülüce et al. The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells
Yao et al. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway
Becker et al. Linalool inhibits the angiogenic activity of endothelial cells by downregulating intracellular ATP levels and activating TRPM8
Hakimuddin et al. Treatment of mcf-7 breast cancer cells with a red grape wine polyphenol fraction results in disruption of calcium homeostasis and cell cycle arrest causing selective cytotoxicity
Eid et al. Molecular insights and cell cycle assessment upon exposure to Chaga (Inonotus obliquus) mushroom polysaccharides in zebrafish (Danio rerio)
WO2009036204A2 (en) Phase ii detoxification and antioxidant activity
Syeda et al. Anthocyanidin attenuates myocardial ischemia induced injury via inhibition of ROS‐JNK‐Bcl‐2 pathway: New mechanism of anthocyanidin action
Akbarpoor et al. The saffron effects on expression pattern of critical self-renewal genes in adenocarcinoma tumor cell line (AGS)
JP6460426B2 (en) Screening method for skin tone improver
TWI480047B (en) Extract of peony root cortex, method of preparing the same and application thereof
Yang et al. Antrodia camphorata induces G 1 cell-cycle arrest in human premyelocytic leukemia (HL-60) cells and suppresses tumor growth in athymic nude mice
Wartenberg et al. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors
EP2762131B1 (en) Use of Salvia Haenkei extracts in compositions for antisenescence
Lee et al. Glycoprotein isolated from Ulmus davidiana Nakai regulates expression of iNOS and COX-2 in vivo and in vitro
TWI483742B (en) Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof
TWI491402B (en) Acetophenone compound extracted from peony root cortex, method of preparing the same and tis application in dna repair